Opioid use disorder
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, al...
Saved in:
Published in | Nature reviews. Disease primers Vol. 6; no. 1; p. 3 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
09.01.2020
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow.
The ongoing epidemic of opioid use disorder includes, in addition to increasing global use of illicitly manufactured heroin and other opioids, a public health crisis aggravated by the over-prescribing of opioid pain medications, in North America particularly. This Primer by Strang, Volkow and colleagues discusses the risk factors of opioid use disorder, together with its epidemiology, mechanisms, diagnosis and treatment. |
---|---|
AbstractList | Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow.The ongoing epidemic of opioid use disorder includes, in addition to increasing global use of illicitly manufactured heroin and other opioids, a public health crisis aggravated by the over-prescribing of opioid pain medications, in North America particularly. This Primer by Strang, Volkow and colleagues discusses the risk factors of opioid use disorder, together with its epidemiology, mechanisms, diagnosis and treatment. Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow. Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow. The ongoing epidemic of opioid use disorder includes, in addition to increasing global use of illicitly manufactured heroin and other opioids, a public health crisis aggravated by the over-prescribing of opioid pain medications, in North America particularly. This Primer by Strang, Volkow and colleagues discusses the risk factors of opioid use disorder, together with its epidemiology, mechanisms, diagnosis and treatment. Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow.Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that drive adverse emotional states and relapse. However, successful recovery is possible with appropriate treatment, although with a persisting propensity to relapse. The individual and public health burdens of OUD are immense; 26.8 million people were estimated to be living with OUD globally in 2016, with >100,000 opioid overdose deaths annually, including >47,000 in the USA in 2017. Well-conducted trials have demonstrated that long-term opioid agonist therapy with methadone and buprenorphine have great efficacy for OUD treatment and can save lives. New forms of the opioid receptor antagonist naltrexone are also being studied. Some frequently used approaches have less scientifically robust evidence but are nevertheless considered important, including community preventive strategies, harm reduction interventions to reduce adverse sequelae from ongoing use and mutual aid groups. Other commonly used approaches, such as detoxification alone, lack scientific evidence. Delivery of effective prevention and treatment responses is often complicated by coexisting comorbidities and inadequate support, as well as by conflicting public and political opinions. Science has a crucial role to play in informing public attitudes and developing fuller evidence to understand OUD and its associated harms, as well as in obtaining the evidence today that will improve the prevention and treatment interventions of tomorrow. |
ArticleNumber | 3 |
Author | Marshall, Brandon D. L. Johnson, Kimberly Strang, John Tyndall, Mark Degenhardt, Louisa Koob, George F. Volkow, Nora D. Walsh, Sharon L. Hickman, Matthew |
Author_xml | – sequence: 1 givenname: John surname: Strang fullname: Strang, John email: john.strang@kcl.ac.uk organization: National Addiction Centre, Institute of Psychiatry Psychology & Neuroscience, King’s College London, South London & Maudsley NHS Foundation Trust – sequence: 2 givenname: Nora D. surname: Volkow fullname: Volkow, Nora D. email: nvolkow@nida.nih.gov organization: National Institute on Drug Abuse, National Institutes of Health – sequence: 3 givenname: Louisa surname: Degenhardt fullname: Degenhardt, Louisa organization: National Drug and Alcohol Research Centre, University of New South Wales – sequence: 4 givenname: Matthew surname: Hickman fullname: Hickman, Matthew organization: Population Health Sciences, Bristol Medical School, University of Bristol – sequence: 5 givenname: Kimberly surname: Johnson fullname: Johnson, Kimberly organization: Department of Mental Health Law and Policy, College of Community and Behavioural Sciences, University of South Florida – sequence: 6 givenname: George F. surname: Koob fullname: Koob, George F. organization: National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health – sequence: 7 givenname: Brandon D. L. surname: Marshall fullname: Marshall, Brandon D. L. organization: Department of Epidemiology, Brown University School of Public Health – sequence: 8 givenname: Mark surname: Tyndall fullname: Tyndall, Mark organization: School of Population and Public Health, University of British Columbia – sequence: 9 givenname: Sharon L. surname: Walsh fullname: Walsh, Sharon L. organization: Department of Behavioral Science, College of Medicine, University of Kentucky |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31919349$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kD1LAzEYgINUbK2dnFyk4OJymu_3MkrxCwpdFNxC7i4nKe2lJneD_96Uqx8U7BDeDM-TvDynaND4xiJ0QfANwSy_jZwIoBkmKh0GmThCI4qFzCTIt8Gf-xBNYlxijInIpcrlCRoyoohiXI3Q-WLjvKumXbTTykUfKhvO0HFtVtFOdnOMXh_uX2ZP2Xzx-Dy7m2clx7jNSJnjMmeFoqQuBAiwYInFlnIjlCSCs8IAVJUCYKXJa5nLooZEcKtqVnE2Rtf9u5vgPzobW712sbSrlWms76KmjEnKJVCZ0Ks9dOm70KTtNEs1MAcK5BBFGacMFE_wGF3uqK5Y20pvglub8Km_oySA9EAZfIzB1j8IwXrbXvftdWqvt-21SA7sOaVrTet80wbjVgdN2psx_dK82_C79P_SF069krc |
CitedBy_id | crossref_primary_10_1007_s40268_023_00443_5 crossref_primary_10_1097_JAN_0000000000000499 crossref_primary_10_3340_jkns_2021_0145 crossref_primary_10_1016_j_healthpol_2024_104993 crossref_primary_10_1016_j_drugalcdep_2022_109581 crossref_primary_10_1016_j_expneurol_2021_113710 crossref_primary_10_1001_jamanetworkopen_2024_51821 crossref_primary_10_3390_chemosensors12040058 crossref_primary_10_1016_j_etap_2022_103902 crossref_primary_10_4103_abr_abr_166_21 crossref_primary_10_1016_j_drugalcdep_2020_108499 crossref_primary_10_1016_j_jss_2024_07_089 crossref_primary_10_37349_eds_2024_00046 crossref_primary_10_1007_s13596_024_00771_0 crossref_primary_10_1097_j_pain_0000000000002280 crossref_primary_10_1007_s13346_022_01202_w crossref_primary_10_14475_jhpc_2023_26_4_185 crossref_primary_10_1177_00220426241269828 crossref_primary_10_1016_j_bpsgos_2025_100476 crossref_primary_10_1177_0310057X211066929 crossref_primary_10_5812_jjcmb_121808 crossref_primary_10_1016_j_encep_2023_07_001 crossref_primary_10_3390_brainsci12080985 crossref_primary_10_1177_1357633X231195607 crossref_primary_10_1016_j_aan_2024_07_005 crossref_primary_10_4103_jfsm_jfsm_55_21 crossref_primary_10_1038_s41572_022_00406_1 crossref_primary_10_1080_14737167_2024_2350561 crossref_primary_10_1111_bph_15656 crossref_primary_10_1177_21582440251326348 crossref_primary_10_1007_s40140_020_00420_7 crossref_primary_10_1016_j_bpsgos_2025_100480 crossref_primary_10_1172_JCI172887 crossref_primary_10_3390_ijms24021633 crossref_primary_10_1016_j_dadr_2024_100218 crossref_primary_10_3390_ijms241310888 crossref_primary_10_1177_07067437221114094 crossref_primary_10_1016_j_jsat_2022_108851 crossref_primary_10_1007_s00213_025_06747_5 crossref_primary_10_1080_17425255_2020_1814737 crossref_primary_10_1016_j_josat_2023_209139 crossref_primary_10_1002_advs_202405352 crossref_primary_10_1016_j_cct_2024_107690 crossref_primary_10_1177_02698811241260989 crossref_primary_10_1097_j_pain_0000000000002860 crossref_primary_10_3389_fphar_2023_1241578 crossref_primary_10_2174_1871527321666220429122819 crossref_primary_10_3390_pharmacy11050164 crossref_primary_10_1080_13543776_2024_2446230 crossref_primary_10_1097_CCM_0000000000006189 crossref_primary_10_1016_j_neuroscience_2023_07_031 crossref_primary_10_1007_s40429_024_00588_6 crossref_primary_10_1016_j_drugpo_2025_104730 crossref_primary_10_1016_j_drugpo_2023_104255 crossref_primary_10_1080_10826084_2022_2076879 crossref_primary_10_1016_j_jen_2023_09_008 crossref_primary_10_1097_JXX_0000000000000944 crossref_primary_10_1016_j_therap_2020_12_009 crossref_primary_10_1038_s41380_022_01501_1 crossref_primary_10_1016_j_neuron_2022_09_024 crossref_primary_10_1093_cid_ciab578 crossref_primary_10_1136_bmjopen_2022_065646 crossref_primary_10_3389_fnbeh_2022_836996 crossref_primary_10_1016_j_cct_2025_107861 crossref_primary_10_1007_s10198_023_01661_z crossref_primary_10_1007_s00414_024_03273_5 crossref_primary_10_1016_j_therap_2023_10_003 crossref_primary_10_1038_s41598_024_60759_3 crossref_primary_10_1111_adb_12982 crossref_primary_10_1016_j_pbb_2021_173294 crossref_primary_10_1111_bph_15677 crossref_primary_10_1016_j_drugalcdep_2021_108649 crossref_primary_10_1080_08897077_2021_1949663 crossref_primary_10_1002_pbc_29665 crossref_primary_10_1002_jcph_1923 crossref_primary_10_1038_s41386_023_01620_5 crossref_primary_10_57187_s_3629 crossref_primary_10_1001_jamanetworkopen_2021_9041 crossref_primary_10_1177_29767342241262556 crossref_primary_10_1089_tmj_2024_0122 crossref_primary_10_1016_j_focus_2024_100269 crossref_primary_10_1111_add_15636 crossref_primary_10_61186_jhc_24_3_193 crossref_primary_10_1111_adb_12977 crossref_primary_10_1016_j_drugalcdep_2020_108335 crossref_primary_10_1111_adb_12970 crossref_primary_10_1080_00952990_2023_2169616 crossref_primary_10_1080_10550887_2024_2431375 crossref_primary_10_3389_fphar_2023_1239159 crossref_primary_10_62401_2531_4122_2025_1 crossref_primary_10_1002_mco2_148 crossref_primary_10_1016_j_ajp_2023_103677 crossref_primary_10_1080_16066359_2024_2373138 crossref_primary_10_1007_s00520_023_07868_3 crossref_primary_10_1177_29767342241248926 crossref_primary_10_1177_10783903221145142 crossref_primary_10_1007_s40140_020_00414_5 crossref_primary_10_1016_j_vascn_2021_107101 crossref_primary_10_3389_fpsyt_2023_1247961 crossref_primary_10_1002_jsfa_13743 crossref_primary_10_1016_j_jneuroim_2023_578204 crossref_primary_10_1016_j_ynstr_2022_100431 crossref_primary_10_1177_26334895231199463 crossref_primary_10_3389_fpubh_2022_811001 crossref_primary_10_1016_j_biopsych_2021_08_005 crossref_primary_10_1016_j_drugalcdep_2020_108327 crossref_primary_10_1128_JVI_01657_20 crossref_primary_10_2147_PPA_S311674 crossref_primary_10_1016_j_therap_2020_05_007 crossref_primary_10_5694_mja2_52603 crossref_primary_10_1016_j_therap_2020_05_008 crossref_primary_10_1080_1533256X_2024_2378687 crossref_primary_10_1111_add_16616 crossref_primary_10_3389_fpsyt_2022_1003257 crossref_primary_10_1016_j_drugpo_2024_104343 crossref_primary_10_1108_FS_02_2023_0026 crossref_primary_10_1080_10550887_2021_2015053 crossref_primary_10_3390_molecules27165211 crossref_primary_10_1016_j_drugalcdep_2024_112535 crossref_primary_10_2196_57367 crossref_primary_10_1186_s13722_023_00402_0 crossref_primary_10_1080_17482631_2022_2094111 crossref_primary_10_1016_j_dadr_2023_100188 crossref_primary_10_1186_s12954_022_00671_z crossref_primary_10_1002_ddr_21789 crossref_primary_10_1186_s12954_022_00656_y crossref_primary_10_1080_00952990_2022_2043335 crossref_primary_10_3389_fpsyt_2024_1316108 crossref_primary_10_1038_s41593_022_01160_z crossref_primary_10_1016_j_healthplace_2024_103296 crossref_primary_10_1016_j_jsat_2021_108646 crossref_primary_10_1007_s40122_023_00481_6 crossref_primary_10_1111_dar_13587 crossref_primary_10_1186_s12954_024_01005_x crossref_primary_10_7759_cureus_42635 crossref_primary_10_1097_YCO_0000000000000870 crossref_primary_10_1007_s40429_025_00626_x crossref_primary_10_1016_j_vaccine_2022_03_053 crossref_primary_10_3389_fnana_2024_1521016 crossref_primary_10_3389_fpsyt_2023_1258029 crossref_primary_10_3390_life14101227 crossref_primary_10_51982_bagimli_1203151 crossref_primary_10_1097_SPC_0000000000000743 crossref_primary_10_3390_healthcare12131268 crossref_primary_10_1016_j_biopsych_2024_05_020 crossref_primary_10_3390_v15030590 crossref_primary_10_1016_j_biopsych_2024_09_008 crossref_primary_10_1016_j_crneur_2021_100023 crossref_primary_10_1080_17441692_2020_1864750 crossref_primary_10_1016_j_addicn_2022_100034 crossref_primary_10_1021_acschemneuro_3c00750 crossref_primary_10_1080_10550887_2024_2354566 crossref_primary_10_1017_S003329172300332X crossref_primary_10_1016_j_jconrel_2022_06_034 crossref_primary_10_1007_s00464_024_11057_6 crossref_primary_10_1016_j_jopan_2022_10_005 crossref_primary_10_1016_j_legalmed_2021_101911 crossref_primary_10_1016_j_drugpo_2024_104399 crossref_primary_10_1097_ADM_0000000000000768 crossref_primary_10_1080_16066359_2023_2282528 crossref_primary_10_1097_MD_0000000000031451 crossref_primary_10_1186_s13011_022_00434_w crossref_primary_10_1080_16066359_2022_2132238 crossref_primary_10_1016_j_bbi_2021_12_014 crossref_primary_10_1016_j_cct_2023_107248 crossref_primary_10_1136_bmjopen_2020_046766 crossref_primary_10_1001_jamapsychiatry_2024_2176 crossref_primary_10_1080_14659891_2025_2474926 crossref_primary_10_36923_jicc_v23i3_122 crossref_primary_10_1007_s40263_024_01069_0 crossref_primary_10_1111_dar_13645 crossref_primary_10_1016_j_addbeh_2020_106681 crossref_primary_10_1186_s43045_022_00224_x crossref_primary_10_1093_pubmed_fdac114 crossref_primary_10_1007_s11916_023_01105_6 crossref_primary_10_1016_j_pmn_2024_03_017 crossref_primary_10_1038_s41386_023_01793_z crossref_primary_10_3389_fpsyt_2023_1205285 crossref_primary_10_7759_cureus_45415 crossref_primary_10_1016_j_dadr_2024_100298 crossref_primary_10_1016_j_gerinurse_2022_05_002 crossref_primary_10_3389_fpubh_2023_1274719 crossref_primary_10_1111_ppc_13030 crossref_primary_10_1097_CXA_0000000000000172 crossref_primary_10_3389_fphar_2022_819470 crossref_primary_10_2147_PRBM_S423802 crossref_primary_10_2196_37351 crossref_primary_10_1093_jalm_jfae169 crossref_primary_10_1007_s00213_024_06557_1 crossref_primary_10_35430_nab_2021_e14 crossref_primary_10_1016_j_pmedr_2023_102305 crossref_primary_10_3389_fpsyg_2021_595883 crossref_primary_10_1111_add_15377 crossref_primary_10_1111_add_15378 crossref_primary_10_1038_s41386_020_00927_x crossref_primary_10_3389_fpsyt_2023_1224376 crossref_primary_10_1016_j_puhe_2023_07_004 crossref_primary_10_1177_1049732320938689 crossref_primary_10_1186_s13722_024_00527_w crossref_primary_10_1016_j_neubiorev_2023_105280 crossref_primary_10_1016_j_mcna_2021_08_009 crossref_primary_10_1016_j_neuropharm_2021_108599 crossref_primary_10_1371_journal_pone_0265283 crossref_primary_10_1080_07853890_2022_2084154 crossref_primary_10_1002_emp2_12606 crossref_primary_10_3390_ijms26062519 crossref_primary_10_7759_cureus_75629 crossref_primary_10_1007_s00213_023_06447_y crossref_primary_10_1159_000529926 crossref_primary_10_1542_pir_2022_005631 crossref_primary_10_1016_j_bbr_2023_114441 crossref_primary_10_1111_add_15818 crossref_primary_10_7759_cureus_28033 crossref_primary_10_1152_jn_00017_2021 crossref_primary_10_1097_YCO_0000000000000717 crossref_primary_10_1016_j_nurpra_2023_104914 crossref_primary_10_1093_ajhp_zxac269 crossref_primary_10_1007_s00213_024_06739_x crossref_primary_10_1016_j_biopsych_2020_12_004 crossref_primary_10_1016_j_jns_2021_120094 crossref_primary_10_1097_FBP_0000000000000780 crossref_primary_10_1016_j_neuropharm_2021_108469 crossref_primary_10_1093_haschl_qxaf036 crossref_primary_10_1089_gtmb_2021_0280 crossref_primary_10_1186_s12913_024_10767_w crossref_primary_10_1016_j_josat_2024_209396 crossref_primary_10_1097_ADT_0000000000000295 crossref_primary_10_1002_aet2_10756 crossref_primary_10_1080_10550887_2022_2044735 crossref_primary_10_1038_s41386_021_01200_5 crossref_primary_10_1186_s40352_024_00291_8 crossref_primary_10_1111_ajad_13455 crossref_primary_10_1126_sciadv_adq4779 crossref_primary_10_1111_bph_16043 crossref_primary_10_1038_s41591_020_0875_7 crossref_primary_10_3390_metabo11030189 crossref_primary_10_1016_j_bjane_2021_06_001 crossref_primary_10_62401_2531_4122_2024_18 crossref_primary_10_3389_fpsyt_2022_893303 crossref_primary_10_3389_fpsyt_2024_1505391 crossref_primary_10_1186_s12889_022_12685_0 crossref_primary_10_5055_jom_0898 crossref_primary_10_1016_j_bbr_2023_114385 crossref_primary_10_1016_j_drugalcdep_2023_111069 crossref_primary_10_1186_s13722_021_00261_7 crossref_primary_10_1177_20534345231213729 crossref_primary_10_1038_s41467_024_55504_3 crossref_primary_10_1089_tmj_2024_0410 crossref_primary_10_1007_s40265_020_01373_1 crossref_primary_10_1016_j_addicn_2024_100187 crossref_primary_10_1111_jcpp_13761 crossref_primary_10_1186_s12888_022_04283_6 crossref_primary_10_1001_jamahealthforum_2022_0093 crossref_primary_10_1097_j_pain_0000000000002878 crossref_primary_10_1038_s41572_020_0175_z crossref_primary_10_1016_j_addicn_2024_100182 crossref_primary_10_3390_brainsci12091166 crossref_primary_10_1111_add_16574 crossref_primary_10_2139_ssrn_4116414 crossref_primary_10_1016_j_tips_2022_03_002 crossref_primary_10_1016_j_neubiorev_2021_04_019 crossref_primary_10_12688_wellcomeopenres_16431_2 crossref_primary_10_7759_cureus_50634 crossref_primary_10_12688_wellcomeopenres_16431_1 crossref_primary_10_1016_j_bbr_2021_113688 crossref_primary_10_54393_pjhs_v4i09_1030 crossref_primary_10_1080_23279095_2024_2336195 crossref_primary_10_1080_14728222_2023_2247563 crossref_primary_10_1097_FBP_0000000000000715 crossref_primary_10_54393_tt_v4i04_184 crossref_primary_10_1159_000519939 crossref_primary_10_1016_j_biomaterials_2024_123041 crossref_primary_10_1136_bmjopen_2022_069778 crossref_primary_10_1016_j_jadohealth_2023_08_047 crossref_primary_10_1515_nipt_2023_0004 crossref_primary_10_1002_dta_3104 crossref_primary_10_1016_j_jpain_2023_05_001 crossref_primary_10_1007_s11916_022_01073_3 crossref_primary_10_1080_00952990_2024_2360984 crossref_primary_10_1016_j_josat_2024_209338 crossref_primary_10_1007_s11469_024_01257_5 crossref_primary_10_1097_BOR_0000000000000868 crossref_primary_10_1210_endrev_bnae023 crossref_primary_10_1126_science_abn7065 crossref_primary_10_1186_s13033_023_00601_x crossref_primary_10_1136_bmjopen_2021_059328 crossref_primary_10_1136_bmjopen_2021_060522 crossref_primary_10_1186_s13063_022_06595_0 crossref_primary_10_1001_jamanetworkopen_2024_55165 crossref_primary_10_5055_jom_0876 crossref_primary_10_1016_j_drugpo_2024_104651 crossref_primary_10_1016_j_drugalcdep_2024_112495 crossref_primary_10_2147_IJGM_S295461 crossref_primary_10_3390_ijms231911804 crossref_primary_10_1016_j_encep_2024_07_003 crossref_primary_10_1186_s13722_024_00475_5 crossref_primary_10_3390_healthcare10020223 crossref_primary_10_1016_j_addbeh_2022_107433 crossref_primary_10_1038_s41380_022_01837_8 crossref_primary_10_1016_j_oooo_2024_07_013 crossref_primary_10_3389_fpsyt_2022_999199 crossref_primary_10_1186_s12875_024_02607_x crossref_primary_10_1186_s13256_024_04483_6 crossref_primary_10_1016_j_josat_2024_209588 crossref_primary_10_62401_2531_4122_2024_54 crossref_primary_10_1377_hlthaff_2020_00378 crossref_primary_10_2196_58723 crossref_primary_10_1016_j_jphs_2023_02_003 crossref_primary_10_1016_j_peh_2024_100275 crossref_primary_10_1016_j_drugpo_2022_103872 crossref_primary_10_1016_j_ajem_2023_06_005 crossref_primary_10_1097_TA_0000000000004180 crossref_primary_10_3389_fncel_2024_1403326 crossref_primary_10_1016_j_pmn_2023_11_002 crossref_primary_10_1080_17425247_2024_2369756 crossref_primary_10_1016_j_josat_2023_209177 crossref_primary_10_1126_sciadv_adr3567 crossref_primary_10_1016_j_therap_2024_09_003 crossref_primary_10_1016_j_ajog_2021_06_067 |
Cites_doi | 10.1016/S2352-3018(18)30168-1 10.1007/BF02245289 10.15585/mmwr.mm6817a3 10.1016/S0740-5472(97)00016-0 10.1111/add.13238 10.1016/j.jsat.2008.09.007 10.1007/978-3-642-41199-1_22 10.1111/add.12337 10.1111/j.1360-0443.1992.tb02743.x 10.1081/ADA-100107660 10.1177/0193841X07307315 10.1136/bmj.e2502 10.1016/j.drugpo.2017.05.023 10.1136/bmj.293.6539.103 10.1038/scientificamerican0304-78 10.1016/j.jsat.2014.05.006 10.1038/nn1578 10.1007/BF01447558 10.1016/j.drugalcdep.2013.08.006 10.1016/j.drugalcdep.2005.11.007 10.1111/j.1360-0443.2011.03575.x 10.1086/449116 10.1111/add.14664 10.1016/S0140-6736(11)60358-9 10.15288/jsad.2015.76.909 10.1016/S1473-3099(16)30325-5 10.1016/S0893-133X(00)00186-X 10.1016/S0306-4522(02)00105-7 10.1111/j.1360-0443.2004.00752.x 10.1007/s002130000637 10.1016/j.drugalcdep.2005.01.013 10.1136/bmj.i19 10.1016/j.jsat.2007.04.015 10.1111/add.13779 10.1111/j.1360-0443.2010.02990.x 10.1111/j.1360-0443.2005.01232.x 10.7326/M17-0865 10.1111/add.12834 10.1016/j.drugalcdep.2014.05.011 10.4103/jehp.jehp_297_13 10.1016/j.drugpo.2010.01.010 10.1097/j.pain.0000000000000837 10.1111/add.13948 10.1080/09687630701731205 10.1001/jamanetworkopen.2019.6373 10.15585/mmwr.rr6501e1 10.1016/j.drugalcdep.2008.07.012 10.1016/S2214-109X(17)30375-3 10.1159/000484239 10.1111/j.1360-0443.2005.001128.x 10.1093/cid/ciu643 10.1001/archpsyc.62.10.1157 10.1523/JNEUROSCI.4291-09.2009 10.1016/j.drugalcdep.2016.06.024 10.1016/j.drugalcdep.2014.09.782 10.1007/s00439-012-1172-4 10.1007/s11121-014-0514-y 10.2146/ajhp070392 10.1001/archpsyc.63.1.102 10.15585/mmwr.mm6614a2 10.4088/JCP.15m10386 10.1080/02791072.1996.10472486 10.1037/a0030743 10.1080/10550887.2012.694597 10.2307/352847 10.1056/NEJMoa055255 10.1016/S0140-6736(16)00161-6 10.1016/0006-8993(82)91123-4 10.2105/AJPH.2018.304673 10.1016/j.biopsych.2015.01.003 10.1016/j.jsat.2017.01.019 10.1111/j.1465-3362.2008.00042.x 10.1001/jamapsychiatry.2017.0113 10.1136/bmj.c3172 10.1111/add.12107 10.1111/add.14012 10.1038/sj.npp.1301008 10.1016/j.ejphar.2014.11.044 10.1007/s10567-007-0023-7 10.1186/s12888-017-1323-1 10.1080/08897077.2016.1261070 10.1016/j.drugpo.2016.10.014 10.1093/jurban/79.3.434 10.1177/0962280208094704 10.1080/08897077.2017.1316812 10.1016/j.drugalcdep.2009.12.001 10.1016/j.drugalcdep.2008.03.003 10.1111/j.1467-842X.2004.tb00629.x 10.1016/j.drugalcdep.2017.05.001 10.1001/archpsyc.58.5.503 10.1001/jamainternmed.2018.1052 10.2105/AJPH.2017.304187 10.1186/s13722-018-0117-1 10.1080/09595230600741024 10.1016/j.tins.2012.11.002 10.1097/00001756-200506210-00026 10.1016/S0193-953X(05)70074-5 10.1016/S0304-3959(00)00391-2 10.1046/j.1360-0443.1999.9421993.x 10.1111/j.1530-0277.2006.00273.x 10.1097/HRP.0000000000000052 10.1016/S2215-0366(19)30209-3 10.1001/jama.2016.1464 10.1136/bmj.c5475 10.1016/S0140-6736(07)60464-4 10.1177/1757913912443487 10.1016/S1550-8579(05)80042-7 10.1038/npp.2014.45 10.1016/j.pbb.2008.07.012 10.1111/add.13073 10.1111/j.1360-0443.2007.02081.x 10.1111/add.12440 10.1007/BF02246290 10.1089/cap.2019.0009 10.1111/add.12056 10.1111/add.13326 10.1038/35047086 10.2147/JPR.S138698 10.1097/ADM.0000000000000312 10.1016/j.conb.2013.03.011 10.1017/S0033291711002145 10.1001/jamainternmed.2014.5302 10.1111/dar.12092 10.1152/physrev.00005.2009 10.1001/jama.2017.9308 10.1016/j.cell.2017.10.035 10.1097/00004583-199410000-00008 10.1016/S0740-5472(00)00124-0 10.1016/j.xphs.2018.08.025 10.1016/j.pain.2010.08.036 10.1001/jamapsychiatry.2013.2216 10.1016/j.drugalcdep.2005.04.007 10.1056/NEJMra1507771 10.1016/S0140-6736(17)31959-1 10.1007/s40265-019-01154-5 10.1007/s00213-002-1027-0 10.1093/cid/ciw416 10.1152/jn.1995.73.2.568 10.1016/j.annemergmed.2019.07.014 10.1016/S0893-133X(00)00195-0 10.1155/2015/368979 10.15288/jsad.2014.75.999 10.1016/S0140-6736(18)33078-2 10.1016/j.drugalcdep.2009.11.008 10.1016/S0140-6736(19)32229-9 10.1080/02791072.2015.1014948 10.1016/S0140-6736(17)32154-2 10.1146/annurev-publhealth-031914-122957 10.1016/S0165-0173(00)00024-2 10.1192/bjp.bp.106.026112 10.1016/S0140-6736(79)91550-2 10.1136/bmj.316.7129.426 10.1001/archgenpsychiatry.2011.121 10.1007/s00213-015-4060-5 10.1016/j.biopsych.2013.08.034 10.1111/add.14053 10.1001/archpsyc.1978.01770280111012 10.1111/papr.12232 10.1056/NEJMc1610047 10.1001/jama.284.13.1689 10.3109/09687637.2015.1100587 10.1016/S2215-0366(16)00002-X 10.15585/mmwr.mm6643e1 10.1001/jamainternmed.2018.1999 10.1111/j.1360-0443.2006.01316.x 10.7326/M17-3107 10.1126/science.288.5472.1769 10.1111/add.13860 10.1093/cid/cit296 10.1016/j.jsat.2016.07.003 10.1038/nrn2515 10.1111/j.1526-4637.2010.00881.x 10.1016/j.jpain.2003.08.003 10.1097/JCP.0000000000000434 10.1080/09595230600741040 10.1111/ajt.13776 10.1046/j.1360-0443.2003.00372.x 10.1001/archpsyc.1973.01750320112017 10.1126/science.aau1184 10.1111/jasp.12434 10.1016/0006-8993(91)91724-F 10.7326/0003-4819-15-5-829 10.1016/S0740-5472(03)00125-9 10.1111/pme.12773 10.1111/j.1369-1600.2008.00142.x 10.1523/JNEUROSCI.0227-08.2008 10.1016/j.drugalcdep.2017.07.018 10.3389/fphar.2014.00253 10.1016/0166-2236(95)93946-U 10.1007/s002139900358 10.1176/ajp.156.6.842 10.1016/j.drugalcdep.2019.02.031 10.1016/j.drugalcdep.2013.10.011 10.1136/bmj.j1550 10.1038/npp.2015.258 10.1016/j.drugalcdep.2005.10.020 10.1056/NEJMsa1406143 10.1056/NEJMoa1505409 10.1016/S0306-4522(98)00652-6 10.1001/jamapsychiatry.2016.0109 10.1136/bmjopen-2013-004666 10.1001/jamanetworkopen.2018.6007 10.1016/S0140-6736(10)60742-8 10.1016/j.drugpo.2014.08.017 10.4088/JCP.v67n0211 10.1016/S0893-133X(96)00184-4 10.1001/archpsyc.1997.01830130077015 10.1016/j.jsat.2007.06.001 10.1523/JNEUROSCI.0740-06.2006 10.1016/j.biopsych.2011.05.025 10.1001/archgenpsychiatry.2012.1a 10.1111/j.1360-0443.2007.01914.x 10.1016/0014-2999(92)90706-A 10.1080/02791072.2003.10400007 10.1007/s11904-018-0396-x 10.1038/255159b0 10.1136/bmj.e5945 10.1038/mp.2015.102 10.1002/car.1100 10.1016/j.drugalcdep.2017.09.006 10.1016/j.jsat.2017.02.011 10.1016/S0140-6736(78)90699-2 10.15585/mmwr.mm6533a2 10.1503/cmaj.170363 10.1016/S2468-2667(18)30232-9 10.1136/bmj.327.7410.310 10.1016/j.drugalcdep.2014.10.012 10.1177/002204268601600106 10.1001/archgenpsychiatry.2008.509 10.3109/00952990.2014.910519 10.1007/978-1-4757-0145-6_1 10.1186/s12913-019-4642-8 10.1111/j.1369-1600.2012.00445.x 10.1056/NEJMp1710014 10.1016/S0140-6736(03)12600-1 10.1111/j.1360-0443.2012.04001.x 10.1016/S0140-6736(11)61674-7 10.1093/ije/dyt243 10.1016/j.jsat.2015.01.009 10.1016/S0140-6736(16)00619-X 10.7326/0003-4819-119-1-199307010-00004 10.1016/S0140-6736(14)62338-2 10.1056/NEJMoa0810635 10.1111/1467-9566.12467 10.1177/0272989X16683928 10.1016/j.pain.2006.10.004 10.1111/j.1360-0443.2009.02754.x 10.1126/science.2903550 10.1093/aje/kwh306 10.4088/JCP.v66n0504 10.1016/j.drugalcdep.2010.11.032 10.1016/j.addbeh.2006.07.013 10.1016/j.jhep.2016.02.007 10.1523/JNEUROSCI.22-12-05100.2002 10.1056/NEJM200011023431802 10.1016/j.drugpo.2011.09.001 10.1016/j.drugalcdep.2005.11.008 10.1016/j.drugalcdep.2007.04.006 10.1111/add.14188 10.1016/j.drugalcdep.2013.01.010 10.1016/S2215-0366(15)00366-1 10.1016/j.jsat.2005.02.007 10.1111/add.13224 10.1016/j.drugpo.2015.09.009 10.1126/science.278.5335.52 10.1016/S0896-6273(00)80110-5 10.1001/jama.2016.9382 10.1038/nrn1431 10.1111/j.1360-0443.2007.01971.x 10.1056/NEJMra1508490 10.1016/j.ejphar.2015.03.081 10.1097/00000542-200008000-00019 10.1007/BF02532387 10.1046/j.1360-0443.1999.9479612.x 10.1016/j.chiabu.2008.09.009 10.1615/CritRevNeurobiol.v14.i1.30 10.1503/cmaj.060863 10.1016/j.drugalcdep.2016.06.006 10.1002/syn.890140210 10.1126/science.841320 10.2471/BLT.12.108282 10.1176/appi.ajp.159.10.1642 10.1038/npp.2009.110 10.1177/0193841X9802200404 10.1186/s12913-018-2830-6 10.1111/add.12536 10.1016/S0140-6736(17)32812-X 10.1056/NEJMra025411 10.1017/S0033291798006667 10.1192/bjp.bp.114.149195 10.1111/add.13453 10.3389/fnins.2015.00466 10.1353/eca.2017.0005 10.1046/j.1460-9568.1998.00083.x 10.1111/adb.12120 10.1016/j.jsat.2004.09.006 10.1159/000444755 10.1016/S0140-6736(10)60349-2 10.1016/S2215-0366(19)30097-5 10.1146/annurev-pharmtox-010716-104615 10.1016/0306-4603(90)90036-W 10.1172/JCI60390 10.1523/JNEUROSCI.1978-13.2015 10.1016/j.drugalcdep.2019.107563 10.1111/add.13783 10.1016/j.jsat.2004.10.013 10.1371/journal.pone.0003351 10.1111/j.1460-9568.2010.07590.x 10.1111/j.1360-0443.2006.01603.x 10.1097/00001756-200301200-00001 10.1016/j.drugalcdep.2013.01.007 10.1016/j.drugalcdep.2016.11.029 10.1111/add.12333 10.1186/1744-8069-9-45 10.1016/S0140-6736(96)90409-2 10.1038/nrg1635 10.1046/j.1360-0443.2003.00354.x 10.1176/ajp.133.1.37 10.1111/j.1360-0443.2011.03602.x 10.1093/bjc/azq038 10.15585/mmwr.mm655051e1 10.1097/ADM.0b013e3181d41ddb 10.1016/S0140-6736(98)05356-2 10.1177/1060028015581848 10.1097/ADM.0000000000000035 10.1111/j.1360-0443.2012.04066.x 10.1080/10550887.2011.581985 10.1016/j.drugalcdep.2015.10.009 10.1037/0033-2909.112.1.64 10.1002/pds.3901 10.1093/oso/9780198818014.001.0001 10.1542/peds.94.3.368 10.1176/appi.books.9780890425596 10.1017/CBO9780511543883 10.1007/978-1-4684-3426-2 10.3109/15360288.2016.1173761 10.1016/B978-0-12-385870-2.00041-X |
ContentType | Journal Article |
Copyright | Springer Nature Limited 2020 2020© Springer Nature Limited 2020 Springer Nature Limited 2020. |
Copyright_xml | – notice: Springer Nature Limited 2020 – notice: 2020© Springer Nature Limited 2020 – notice: Springer Nature Limited 2020. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M2P M7P PHGZM PHGZT PKEHL PQEST PQGLB PQQKQ PQUKI Q9U 7X8 |
DOI | 10.1038/s41572-019-0137-5 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) ProQuest One Academic (New) MEDLINE - Academic |
DatabaseTitleList | ProQuest Central Student MEDLINE MEDLINE - Academic ProQuest Central Student |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 2056-676X |
ExternalDocumentID | 31919349 10_1038_s41572_019_0137_5 |
Genre | Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: P20 GM125507 – fundername: Department of Health grantid: RP-PG-0616-20008 – fundername: Department of Health grantid: 12/136/105 |
GroupedDBID | 0R~ 53G 7X7 88I 8FI 8FJ AAEEF AARCD AAWYQ AAYZH AAZLF ABJNI ABLJU ABUWG ACGFS ACMJI ADBBV AFKRA AFSHS AGAYW AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS ARMCB AXYYD AZQEC BENPR BKKNO BPHCQ BVXVI CCPQU DWQXO EBS FQGFK FSGXE FYUFA FZEXT GNUQQ HCIFZ HMCUK LGEZI LOTEE M2P NADUK NNMJJ NXXTH PQQKQ PROAC R9- RNR RNT SHXYY SIXXV SNYQT SOJ TAOOD TBHMF TDRGL TSG UKHRP AAYXX ABFSG ACMFV ACSTC AEZWR AFANA AFHIU AHWEU AIXLP ATHPR BBNVY BHPHI CITATION M7P PHGZM PHGZT CGR CUY CVF ECM EIF NPM PQGLB 3V. 7XB 8FE 8FH 8FK K9. LK8 PKEHL PQEST PQUKI Q9U 7X8 |
ID | FETCH-LOGICAL-c400t-1c80c83b921fb5757e7e1e0e24a5961543ba77dd9773ca8f686bf71e04e9f3d43 |
IEDL.DBID | 7X7 |
ISSN | 2056-676X |
IngestDate | Fri Jul 11 05:22:03 EDT 2025 Sat Aug 23 14:05:59 EDT 2025 Wed Jul 16 16:37:42 EDT 2025 Mon Jul 21 06:05:06 EDT 2025 Tue Jul 01 02:52:21 EDT 2025 Thu Apr 24 22:58:48 EDT 2025 Fri Feb 21 02:37:58 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c400t-1c80c83b921fb5757e7e1e0e24a5961543ba77dd9773ca8f686bf71e04e9f3d43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
PMID | 31919349 |
PQID | 2342379410 |
PQPubID | 2069613 |
ParticipantIDs | proquest_miscellaneous_2336246726 proquest_journals_3103047271 proquest_journals_2342379410 pubmed_primary_31919349 crossref_primary_10_1038_s41572_019_0137_5 crossref_citationtrail_10_1038_s41572_019_0137_5 springer_journals_10_1038_s41572_019_0137_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-01-09 |
PublicationDateYYYYMMDD | 2020-01-09 |
PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-09 day: 09 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature reviews. Disease primers |
PublicationTitleAbbrev | Nat Rev Dis Primers |
PublicationTitleAlternate | Nat Rev Dis Primers |
PublicationYear | 2020 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Bickel (CR274) 1988; 247 Aspinall (CR236) 2014; 43 Nelson (CR35) 2014; 19 Bossert, Busch, Gray (CR130) 2005; 16 Chase, Eickhoff, Laird, Hogarth (CR138) 2011; 70 Milloy, Kerr, Tyndall, Montaner, Wood (CR243) 2008; 3 Walsh (CR284) 1995; 119 Low (CR218) 2016; 63 Rhodes, Wilson, Robinson, Hayden, Asbridge (CR199) 2019; 19 Lynskey, Fergusson (CR60) 1995; 23 Strain, Stitzer, Liebson, Bigelow (CR276) 1993; 119 Krupitsky (CR308) 2012; 69 Bester, Menendez, Besson, Bernard (CR172) 1995; 73 Rich, Bia, Altice, Feinberg (CR251) 2018; 15 Chartoff, Mavrikaki (CR154) 2015; 9 Somerville (CR79) 2017; 66 Dowell, Haegerich, Chou (CR41) 2016; 65 Epstein (CR137) 2009; 66 Campbell (CR59) 2015; 16 Degenhardt (CR7) 2011; 117 CR174 Strang (CR238) 2008; 15 Dowell (CR348) 2017; 318 Kakko, Svanborg, Kreek, Heilig (CR258) 2003; 361 CR291 O’Donnell, Halpin, Mattson, Goldberger, Gladden (CR75) 2017; 66 Raehal, Bohn (CR105) 2014; 219 Meier (CR255) 2014; 40 Laulin, Celerier, Larcher, Le Moal, Simonnet (CR99) 1999; 89 Brady, Randall (CR153) 1999; 22 Kelly, Humphreys, Ferri (CR329) 2019; 9 De Leon, Hawke, Jainchill, Melnick (CR331) 2000; 19 Tsui (CR162) 2016; 166 Amato, Minozzi, Davoli, Vecchi (CR317) 2011; 5 Rossetti, Hmaidan, Gessa (CR114) 1992; 221 CR152 CR273 Rosenthal (CR289) 2016; 316 Saha (CR34) 2016; 77 Nutt, King, Saulsbury, Blakemore (CR18) 2007; 369 Pierce, Bird, Hickman, Millar (CR177) 2015; 146 O’Brien, McLellan (CR223) 1996; 347 Marsch (CR354) 2005; 62 CR386 CR387 Day, Degenhardt, Hall (CR187) 2006; 25 Kreek (CR132) 1996; 1 Strang (CR302) 2015; 207 Connock (CR219) 2007; 11 Zijlstra, Veltman, Booij, van den Brink, Franken (CR116) 2009; 99 Kuhn, Gallinat (CR139) 2011; 33 Amato, Minozzi, Davoli, Vecchi (CR263) 2011; 9 Stone (CR230) 2017; 112 Volkow (CR83) 2016; 352 Degenhardt (CR225) 2014; 109 Jensen (CR148) 2016; 2 Goldstein, Volkow (CR89) 2002; 159 Panebianco, Gallupe, Carrington, Colozzi (CR381) 2016; 27 Stringer, Welsh, Tommasello (CR281) 2009; 66 Larney (CR228) 2014; 4 Seaman, Brettle, Gore (CR260) 1998; 316 Garner, Scott, Dennis, Funk (CR371) 2014; 47 Gossop (CR264) 1990; 15 White (CR368) 2005; 23 Sordo (CR22) 2017; 357 CR250 Gossop, Johns, Green (CR267) 1986; 293 Muller, Skurtveit, Clausen (CR382) 2017; 180 Volkow, Hampson, Baler (CR124) 2017; 57 Vijay (CR158) 2016; 6 CR246 Wang (CR115) 1997; 16 Haegerich, Jones, Cote, Robinson, Ross (CR200) 2019; 204 Haffajee, Lin, Bohnert, Goldstick (CR193) 2019; 2 Fischer, Pang, Tyndall (CR350) 2019; 4 Feng, Zhu, Zhou (CR278) 2017; 10 Rubin (CR17) 2017; 318 Nestler, Malenka (CR142) 2004; 290 Hser (CR288) 2016; 111 Frenk, Porter, Paulozzi (CR12) 2015; 189 Martins (CR71) 2012; 42 Gelernter (CR149) 2014; 76 Lutz, Kieffer (CR92) 2013; 36 Ballantyne, Mao (CR191) 2003; 349 Dennis, Scott, Funk, Foss (CR339) 2005; 28 Konkoly Thege (CR68) 2017; 17 Whitfield (CR121) 2015; 35 Dowell, Haegerich, Chou (CR36) 2016; 65 MacArthur (CR214) 2012; 345 Dunn (CR306) 2013; 21 Compton, Volkow (CR48) 2006; 83 Al Achkar (CR197) 2018; 18 Brooner, King, Kidorf, Schmidt, Bigelow (CR253) 1997; 54 Sadeghi, Davaridolatabadi, Rahmani, Ghodousi, Ziaeirad (CR358) 2017; 6 CR221 CR101 Nasser (CR290) 2016; 36 Nielsen (CR147) 2015; 15 Stinus, Caille, Koob (CR134) 2000; 149 Kelly, Greene (CR322) 2013; 133 Gaspari (CR103) 2014; 39 Kariisa, Scholl, Wilson, Seth, Hoots (CR204) 2019; 68 Gold, Redmond, Kleber (CR271) 1978; 1 Carlezon, Nestler, Neve (CR123) 2000; 14 CR313 Humphreys, Lembke (CR369) 2014; 33 CR314 CR312 Mayet, Farrell, Ferri, Amato, Davoli (CR360) 2005; 25 Koob, Le Moal (CR90) 1997; 278 CR315 CR316 Butt, Chou, Browne (CR67) 2011; 20 Hickman (CR234) 2018; 113 Roxburgh (CR351) 2017; 179 Blanken, Hendriks, van Ree, van den Brink (CR303) 2010; 105 Foxcroft, Tsertsvadze (CR182) 2012; 132 White (CR325) 2007; 33 Doverty (CR161) 2001; 90 CR324 Termorshuizen (CR28) 2005; 79 Jasinski, Pevnick, Griffith (CR282) 1978; 35 CR209 Volkow, McLellan (CR108) 2016; 374 CR207 CR208 Marsden (CR224) 2017; 112 Platt (CR215) 2018; 113 Guignard (CR98) 2000; 93 Beck (CR294) 2014; 109 Neale (CR377) 2016; 165 Schmid (CR107) 2017; 171 Davis, Carr (CR44) 2017; 38 Donny, Brasser, Bigelow, Stitzer, Walsh (CR277) 2005; 100 Fiellin (CR257) 2014; 174 Case, Deaton (CR353) 2017; 2017 Compton, Jones, Baldwin (CR206) 2016; 374 Petrar (CR244) 2007; 32 Dasgupta, Beletsky, Ciccarone (CR72) 2018; 108 Zhang, Friedmann, Gerstein (CR361) 2003; 98 Ren, Whittard, Higuera-Matas, Morris, Hurd (CR163) 2009; 29 Larochelle (CR310) 2018; 169 Hawk, D’Onofrio (CR334) 2018; 13 Barocas (CR5) 2018; 108 Levine (CR362) 2015; 54 Reuter, Kleiman (CR185) 1986; 7 Mathers (CR212) 2013; 91 Fields (CR104) 2004; 5 Jalal (CR186) 2018; 361 Scott, Foss, Dennis (CR343) 2005; 28 Paulozzi, Mack, Hockenberry (CR39) 2014; 63 Carcoba, Contreras, Cepeda-Benito, Meagher (CR164) 2011; 30 Neugebauer (CR170) 2007; 127 Matson, Hobson, Abdel-Rasoul, Bonny (CR364) 2014; 8 Stewart, Wise (CR127) 1992; 108 Simpson, Joe, Lehman, Sells (CR340) 1986; 16 Gladden, Martinez, Seth (CR76) 2016; 65 Oviedo-Joekes (CR301) 2009; 361 Gibson, Randall, Degenhardt (CR178) 2011; 106 Sweeting, De Angelis, Ades, Hickman (CR25) 2009; 18 Wesson, Ling (CR265) 2003; 35 CR3 CR6 Kalivas (CR128) 2009; 10 Krupitsky (CR307) 2011; 377 Koob, Bloom (CR117) 1988; 242 Hadland, Cerda, Li, Krieger, Marshall (CR42) 2018; 178 Kimber, Larney, Hickman, Randall, Degenhardt (CR24) 2015; 2 Hser, Evans, Grella, Ling, Anglin (CR342) 2015; 23 Hadland, Rivera-Aguirre, Marshall, Cerda (CR43) 2019; 2 Hser (CR363) 2014; 109 Neale (CR378) 2015; 23 Squeglia, Fadus, McClure, Tomko, Gray (CR283) 2019 Ward, Hall, Mattick (CR355) 1999; 353 Petry, Stinson, Grant (CR254) 2005; 66 Morgan, Schackman, Weinstein, Walley, Linas (CR311) 2019; 200 Rosado, Walsh, Bigelow, Strain (CR286) 2007; 90 Moyo (CR198) 2017; 112 Strang, McDonald, Campbell, Degenhardt, Nielsen, Ritter, Dale (CR332) 2019; 79 Laulin, Larcher, Celerier, Le Moal, Simonnet (CR165) 1998; 10 Georgie, Sean, Deborah, Matthew, Rona (CR184) 2016; 111 Gisev (CR220) 2015; 110 Lofwall (CR292) 2018; 178 Nestler (CR140) 1996; 16 Rich (CR227) 2015; 386 Greenwell, Walker, Cottone, Zorrilla, Koob (CR119) 2009; 91 Stockings (CR183) 2016 Cepeda (CR232) 2018; 5 Walsh, Strain, Bigelow (CR269) 2003; 98 Yiannakopoulou (CR145) 2015; 2015 Mucha, van der Kooy, O’Shaughnessy, Bucenieks (CR96) 1982; 243 Stewart, Henderson, Hobbs, Ridout, Knuiman (CR335) 2004; 28 Nosyk (CR357) 2015; 157 Sigmon (CR320) 2016; 375 Mattick, Breen, Kimber, Davoli (CR211) 2009; 8 Kreek (CR19) 2012; 122 Fraser (CR231) 2018; 113 Meemken, Hanhoff, Tseng, Christensen, Gillessen (CR280) 2015; 49 De Angelis, Hickman, Yang (CR26) 2004; 160 Kenny, Chen, Kitamura, Markou, Koob (CR136) 2006; 26 Martin (CR100) 1973; 28 Volpe, Xu, Sahajwalla, Younis, Patel (CR279) 2018; 107 Zinberg, Jacobson (CR20) 1976; 133 Suryaprasad (CR81) 2014; 59 Malekinejad, Vazirian (CR10) 2012; 23 Darke, Torok, Ross (CR69) 2017; 47 Gordon (CR337) 2014; 142 Donny, Walsh, Bigelow, Eissenberg, Stitzer (CR275) 2002; 161 Godfrey, Stewart, Gossop (CR217) 2004; 99 Hancock (CR146) 2015; 78 Newman, Whitehill (CR259) 1979; 2 Chen (CR95) 2006; 31 Laudet (CR373) 2011; 6 Feelemyer, Jarlais, Arasteh, Phillips, Hagan (CR372) 2014; 134 Strang (CR300) 2010; 375 Gjersing, Bretteville-Jensen (CR344) 2018; 113 Wood, Tyndall, Montaner, Kerr (CR245) 2006; 175 Barnett, Gray, Zink, Jena (CR203) 2017; 377 Dowell, Haegerich, Chou (CR37) 2016; 315 Mehta (CR31) 2012; 107 Degenhardt, Larney, Randall, Burns, Hall (CR346) 2014; 109 Luchenski (CR189) 2018; 391 Lee (CR336) 2016; 374 Khademi (CR9) 2012; 344 Volkow (CR125) 1993; 14 McNally, Akil (CR173) 2002; 112 McLellan, Lewis, O’Brien, Kleber (CR222) 2000; 284 Degenhardt (CR73) 2010; 108 Simonnet, Rivat (CR159) 2003; 14 Shah, Galai, Celentano, Vlahov, Strathdee (CR29) 2006; 83 Fischer, Russell, Murphy, Kurdyak (CR77) 2015; 24 Cahill (CR102) 2014; 5 Greenwell (CR118) 2009; 14 Bossert (CR129) 2016; 233 Nguyen Bich, Korthuis, Nguyen Thu, Van Dinh, Le Minh (CR252) 2016; 69 Katz, El-Gabalawy, Keyes, Martins, Sareen (CR62) 2013; 132 Carroll, Marshall, Rich, Green (CR78) 2017; 46 Merrall (CR23) 2010; 105 Merrall, Bird, Hutchinson (CR262) 2013; 108 Degenhardt (CR86) 2017; 5 Maloney, Degenhardt, Darke, Mattick, Nelson (CR85) 2007; 102 Martin (CR235) 2016; 65 Le Merrer, Becker, Befort, Kieffer (CR97) 2009; 89 Minozzi (CR305) 2011; 16 Latowsky (CR109) 1996; 28 Berterame (CR190) 2016; 87 Rudd, Aleshire, Zibbell, Matthew Gladden (CR74) 2016; 16 Zubieta, Dannals, Frost (CR156) 1999; 156 Shurman, Koob, Gutstein (CR169) 2010; 11 Nestler (CR383) 2005; 8 Fu, Neugebauer (CR166) 2008; 28 Larney, Peacock, Mathers, Hickman, Degenhardt (CR88) 2017; 171 Fiellin (CR319) 2006; 355 Bohn, Gainetdinov, Lin, Lefkowitz, Caron (CR106) 2000; 408 Darke (CR347) 2015; 76 Razani (CR11) 2007; 102 Kimber (CR30) 2010; 341 Daniel (CR54) 2009; 28 Knudsen, Abraham, Roman (CR359) 2011; 5 Dart (CR13) 2015; 372 Zibbell (CR82) 2015; 64 Koob (CR112) 2015; 753 Cornish, Macleod, Strang, Vickerman, Hickman (CR233) 2010; 341 Platt (CR216) 2017; 9 Degenhardt (CR33) 2010; 376 Kertesz (CR205) 2017; 38 Vos (CR8) 2017; 390 Robertson (CR297) 2006; 101 Nelson (CR150) 2016; 21 Burns (CR365) 2015; 110 White (CR326) 2012; 31 Ford, Rigg (CR50) 2015; 16 Compton, Athanasos, Elashoff (CR160) 2003; 4 Pirastu (CR126) 2006; 83 Levran, Yuferov, Kreek (CR144) 2012; 131 Park (CR120) 2015; 20 Eder (CR293) 2005; 100 Himmelsbach (CR266) 1941; 15 van den Brink (CR298) 2003; 327 Shaham, Erb, Stewart (CR131) 2000; 33 Chavkin, Koob (CR122) 2016; 41 Lee (CR309) 2018; 391 Taylor (CR229) 2013; 108 Hser, Grella, Chou, Douglas Anglin (CR379) 1998; 22 Flynn, Joe, Broome, Simpson, Brown (CR380) 2003; 25 White, Irvine (CR176) 1999; 94 Blanco, Volkow (CR1) 2019; 393 Degenhardt (CR38) 2019; 394 Mansour, Fox, Akil, Watson (CR91) 1995; 18 Humphreys, Moos (CR323) 2007; 31 Martins (CR16) 2017; 74 Macleod (CR66) 2013; 108 Cousins, Crevecoeur-MacPhail, Kim, Rawson (CR366) 2018; 85 Lee, Ho (CR151) 2013; 9 Conway, Compton, Stinson, Grant (CR256) 2006; 67 Stoller, Bigelow, Walsh, Strain (CR285) 2001; 154 Krebs (CR341) 2017; 37 Felix, Portugal (CR248) 2017; 39 Strang (CR237) 1999; 94 CR47 Needle, Su, Doherty (CR58) 1990; 52 CR46 Darke (CR70) 2013; 108 Goldman, Oroszi, Ducci (CR143) 2005; 6 CR45 Farrell, Marsden (CR261) 2008; 103 De Maeyer, Vanderplasschen, Broekaert (C S Berterame (137_CR190) 2016; 87 J Neale (137_CR378) 2015; 23 SH Mehta (137_CR31) 2012; 107 SM Frenk (137_CR12) 2015; 189 C Godfrey (137_CR217) 2004; 99 M Farrell (137_CR261) 2008; 103 A Mansour (137_CR91) 1995; 18 KP Conway (137_CR256) 2006; 67 KM Raehal (137_CR105) 2014; 219 EJ Nestler (137_CR140) 1996; 16 GJ MacArthur (137_CR214) 2012; 345 YI Hser (137_CR338) 1997; 14 SE Hadland (137_CR43) 2019; 2 ND Volkow (137_CR124) 2017; 57 L Degenhardt (137_CR346) 2014; 109 E Stockings (137_CR183) 2016 J Kakko (137_CR258) 2003; 361 CS Davis (137_CR44) 2017; 38 K Humphreys (137_CR323) 2007; 31 RP Mattick (137_CR211) 2009; 8 Y-I Hser (137_CR379) 1998; 22 NJ Somerville (137_CR79) 2017; 66 RK Brooner (137_CR253) 1997; 54 W van den Brink (137_CR298) 2003; 327 EC Donny (137_CR277) 2005; 100 JJ Carroll (137_CR78) 2017; 46 R McDonald (137_CR239) 2017 L Strada (137_CR374) 2017; 23 137_CR65 Z Wiesenfeld-Hallin (137_CR155) 2005; 2 M Amin-Esmaeili (137_CR49) 2016; 111 S Petrar (137_CR244) 2007; 32 P Reuter (137_CR185) 1986; 7 S Mayet (137_CR360) 2005; 25 137_CR64 LM Stewart (137_CR335) 2004; 28 J Hawkins (137_CR53) 1992; 112 L Townsend (137_CR61) 2007; 10 G Simonnet (137_CR159) 2003; 14 JP Laulin (137_CR165) 1998; 10 J Ward (137_CR355) 1999; 353 MR Larochelle (137_CR310) 2018; 169 C Day (137_CR187) 2006; 25 137_CR94 F Termorshuizen (137_CR28) 2005; 79 EJ Aspinall (137_CR236) 2014; 43 C Katz (137_CR62) 2013; 132 137_CR93 D Goldman (137_CR143) 2005; 6 THE WHOQOL GROUP (137_CR375) 1998; 28 D Dowell (137_CR36) 2016; 65 RP Schwartz (137_CR321) 2006; 63 A Kolodny (137_CR40) 2015; 36 L Stinus (137_CR134) 2000; 149 D Dowell (137_CR348) 2017; 318 ZL Rossetti (137_CR114) 1992; 221 MT Lynskey (137_CR60) 1995; 23 137_CR84 GJ Wang (137_CR115) 1997; 16 137_CR80 JR Morgan (137_CR311) 2019; 200 CP O’Brien (137_CR110) 1977; 195 M Meini (137_CR295) 2015 B Nosyk (137_CR357) 2015; 157 WL White (137_CR368) 2005; 23 BM Mathers (137_CR212) 2013; 91 GF Koob (137_CR167) 2010; 35 J Gelernter (137_CR149) 2014; 76 JC Ballantyne (137_CR191) 2003; 349 E Oviedo-Joekes (137_CR304) 2016; 73 J Stewart (137_CR127) 1992; 108 JW Busse (137_CR196) 2017; 189 SC Matson (137_CR364) 2014; 8 YI Hser (137_CR345) 2017; 11 AJ Low (137_CR218) 2016; 63 J O’Donnell (137_CR75) 2017; 66 AB Laudet (137_CR373) 2011; 6 N Dasgupta (137_CR72) 2018; 108 YI Hser (137_CR342) 2015; 23 J Marsden (137_CR224) 2017; 112 JW Bray (137_CR370) 2017; 76 JE Zibbell (137_CR82) 2015; 64 L Amato (137_CR210) 2005; 28 M Connock (137_CR219) 2007; 11 R Cornish (137_CR233) 2010; 341 T Beck (137_CR294) 2014; 109 L Platt (137_CR216) 2017; 9 C Blanco (137_CR1) 2019; 393 U Verthein (137_CR296) 2005; 80 JF Kelly (137_CR329) 2019; 9 KN Gracy (137_CR135) 2001; 24 L Gjersing (137_CR344) 2018; 113 EC Donny (137_CR275) 2002; 161 M Gossop (137_CR267) 1986; 293 J Shurman (137_CR169) 2010; 11 H Bester (137_CR172) 1995; 73 R Pirastu (137_CR126) 2006; 83 S Larney (137_CR228) 2014; 4 CW Lee (137_CR151) 2013; 9 GF Koob (137_CR112) 2015; 753 A Gibson (137_CR178) 2011; 106 GF Koob (137_CR117) 1988; 242 L Heimer (137_CR111) 1991; 295 M Kariisa (137_CR204) 2019; 68 C Chavkin (137_CR122) 2016; 41 EJ Nestler (137_CR142) 2004; 290 RF Mucha (137_CR96) 1982; 243 B Guignard (137_CR98) 2000; 93 M Hickman (137_CR234) 2018; 113 HW Chase (137_CR138) 2011; 70 J Strang (137_CR237) 1999; 94 LJ Paulozzi (137_CR39) 2014; 63 V Neugebauer (137_CR170) 2007; 127 Y Ren (137_CR163) 2009; 29 F Zijlstra (137_CR116) 2009; 99 TM Haegerich (137_CR200) 2019; 204 A Roxburgh (137_CR351) 2017; 179 AF Nasser (137_CR290) 2016; 36 DA Fiellin (137_CR319) 2006; 355 DH Epstein (137_CR137) 2009; 66 L Degenhardt (137_CR87) 2016; 16 D Dowell (137_CR37) 2016; 315 JF Kelly (137_CR322) 2013; 133 WA Carlezon Jr. (137_CR123) 2000; 14 M Pierce (137_CR177) 2015; 146 KM Rich (137_CR251) 2018; 15 S Darke (137_CR70) 2013; 108 PM Flynn (137_CR380) 2003; 25 JM Georgie (137_CR184) 2016; 111 RA Rudd (137_CR74) 2016; 16 SL Walsh (137_CR269) 2003; 98 LM Bohn (137_CR106) 2000; 408 CK Himmelsbach (137_CR266) 1941; 15 Y Shaham (137_CR131) 2000; 33 MS Gordon (137_CR337) 2014; 142 J Csete (137_CR179) 2016; 387 L Degenhardt (137_CR73) 2010; 108 G Melnick (137_CR330) 2001; 27 M Malekinejad (137_CR10) 2012; 23 SC Sigmon (137_CR272) 2013; 70 WK Bickel (137_CR274) 1988; 247 JK Zubieta (137_CR157) 2002; 22 EH Chartoff (137_CR154) 2015; 9 E Krebs (137_CR341) 2017; 37 SC Sigmon (137_CR320) 2016; 375 SE Hadland (137_CR42) 2018; 178 J Marsden (137_CR4) 2019; 6 NG Shah (137_CR29) 2006; 83 NE Zinberg (137_CR20) 1976; 133 BR Garner (137_CR371) 2014; 47 PE Park (137_CR120) 2015; 20 SJ Cousins (137_CR366) 2018; 85 K Stoller (137_CR285) 2001; 154 MJ Sweeting (137_CR25) 2009; 18 RD Weiss (137_CR318) 2011 S Darke (137_CR347) 2015; 76 M Gold (137_CR271) 1978; 1 SG Kertesz (137_CR205) 2017; 38 JM White (137_CR176) 1999; 94 SG Mitchell (137_CR356) 2015; 47 MJ Kreek (137_CR132) 1996; 1 SA Chen (137_CR95) 2006; 31 CE Hughes (137_CR247) 2010; 50 D De Angelis (137_CR26) 2004; 160 RH Needle (137_CR58) 1990; 52 PE Lutz (137_CR92) 2013; 36 ND Volkow (137_CR108) 2016; 374 EC Nelson (137_CR150) 2016; 21 L A Lin (137_CR201) 2017; 158 JM Bossert (137_CR129) 2016; 233 A Case (137_CR353) 2017; 2017 L Degenhardt (137_CR33) 2010; 376 137_CR51 NM Petry (137_CR254) 2005; 66 B Konkoly Thege (137_CR68) 2017; 17 C Potier (137_CR242) 2014; 145 E Ravndal (137_CR333) 2010; 108 N Razani (137_CR11) 2007; 102 DM Fergusson (137_CR52) 2008; 96 E Wood (137_CR245) 2006; 175 RG Newman (137_CR259) 1979; 2 TD Saha (137_CR34) 2016; 77 137_CR47 JZ Daniel (137_CR54) 2009; 28 137_CR45 137_CR46 L A Kaskutas (137_CR367) 2014; 75 MA Irvine (137_CR202) 2019; 114 H Khademi (137_CR9) 2012; 344 L Sordo (137_CR22) 2017; 357 G Campbell (137_CR59) 2015; 16 137_CR315 137_CR316 CP O’Brien (137_CR223) 1996; 347 137_CR313 MR Lofwall (137_CR292) 2018; 178 137_CR314 137_CR312 AT McLellan (137_CR222) 2000; 284 SS Martins (137_CR16) 2017; 74 HO Collier (137_CR141) 1975; 255 J Strang (137_CR238) 2008; 15 S Kuhn (137_CR139) 2011; 33 CK Scott (137_CR343) 2005; 28 YI Hser (137_CR21) 2001; 58 L Amato (137_CR263) 2011; 9 G Ridge (137_CR270) 2009; 37 YI Hser (137_CR32) 2007; 31 H Fields (137_CR104) 2004; 5 J Le Merrer (137_CR97) 2009; 89 F Faggiano (137_CR181) 2014; 12 137_CR324 JA Barocas (137_CR5) 2018; 108 T Vos (137_CR8) 2017; 390 M Latowsky (137_CR109) 1996; 28 EC Strain (137_CR276) 1993; 119 H Eder (137_CR293) 2005; 100 MJ Milloy (137_CR243) 2008; 3 S Larney (137_CR88) 2017; 171 CM Cahill (137_CR102) 2014; 5 JD Lee (137_CR309) 2018; 391 O Levran (137_CR144) 2012; 131 WL White (137_CR325) 2007; 33 TN Greenwell (137_CR119) 2009; 91 MJ Kreek (137_CR133) 1996; 21 DA Volpe (137_CR279) 2018; 107 L Meemken (137_CR280) 2015; 49 D Nutt (137_CR18) 2007; 369 S Minozzi (137_CR305) 2011; 16 WL White (137_CR326) 2012; 31 JA Ford (137_CR50) 2015; 16 TW Whitfield Jr (137_CR121) 2015; 35 MJ Kreek (137_CR19) 2012; 122 GF Koob (137_CR168) 2001; 24 WM Compton (137_CR48) 2006; 83 L Platt (137_CR215) 2018; 113 M Al Achkar (137_CR197) 2018; 18 J Kimber (137_CR30) 2010; 341 L Degenhardt (137_CR7) 2011; 117 J Strang (137_CR302) 2015; 207 L Amato (137_CR317) 2011; 5 L Burns (137_CR365) 2015; 110 EL Merrall (137_CR23) 2010; 105 JA Cepeda (137_CR232) 2018; 5 N Gisev (137_CR220) 2015; 110 C Haasen (137_CR299) 2007; 191 N Krawczyk (137_CR192) 2019 SR Seaman (137_CR260) 1998; 316 DM Fergusson (137_CR56) 1994; 33 MD Sullivan (137_CR63) 2010; 151 J Kimber (137_CR24) 2015; 2 J De Maeyer (137_CR376) 2010; 21 KP Jensen (137_CR148) 2016; 2 EC Nelson (137_CR35) 2014; 19 WR Martin (137_CR100) 1973; 28 DB Hancock (137_CR146) 2015; 78 YI Hser (137_CR288) 2016; 111 GP McNally (137_CR173) 2002; 112 137_CR246 EL Merrall (137_CR262) 2013; 108 K Humphreys (137_CR369) 2014; 33 RA Rudd (137_CR349) 2016; 65 E Krupitsky (137_CR307) 2011; 377 J Strang (137_CR2) 2012; 379 L Degenhardt (137_CR225) 2014; 109 E Krupitsky (137_CR308) 2012; 69 R Gladden (137_CR76) 2016; 65 J Kimber (137_CR352) 2019; 6 R Rubin (137_CR17) 2017; 318 JD Rich (137_CR227) 2015; 386 RE Johnson (137_CR287) 2000; 343 J Gfroerer (137_CR27) 1992; 87 J Stone (137_CR230) 2017; 112 A Taylor (137_CR229) 2013; 108 137_CR209 137_CR207 137_CR208 E Drucker (137_CR180) 2002; 79 JR Robertson (137_CR297) 2006; 101 DD Simpson (137_CR340) 1986; 16 L A Marsch (137_CR354) 2005; 62 137_CR221 137_CR101 J Stringer (137_CR281) 2009; 66 E Pothos (137_CR113) 1991; 566 137_CR3 R McDonald (137_CR240) 2016; 111 ML Barnett (137_CR203) 2017; 377 137_CR6 J Neale (137_CR377) 2016; 165 A Meier (137_CR255) 2014; 40 DA Cohen (137_CR55) 1994; 94 HK Knudsen (137_CR359) 2011; 5 E Yiannakopoulou (137_CR145) 2015; 2015 KE Dunn (137_CR306) 2013; 21 A Vijay (137_CR158) 2016; 6 EJ Nestler (137_CR383) 2005; 8 B Fischer (137_CR77) 2015; 24 S Felix (137_CR248) 2017; 39 D Panebianco (137_CR381) 2016; 27 137_CR152 137_CR273 ND Volkow (137_CR125) 1993; 14 CL Schmid (137_CR107) 2017; 171 P Blanken (137_CR303) 2010; 105 P Compton (137_CR160) 2003; 4 DD Price (137_CR171) 2000; 288 S Darke (137_CR69) 2017; 47 N Sadeghi (137_CR358) 2017; 6 DR Foxcroft (137_CR182) 2012; 132 S Gaspari (137_CR103) 2014; 39 RN Rosenthal (137_CR289) 2016; 316 JI Tsui (137_CR162) 2016; 166 John Strang (137_CR332) 2019; 79 RL Haffajee (137_CR193) 2019; 2 NK Martin (137_CR385) 2013; 57 J Strang (137_CR300) 2010; 375 JD Lee (137_CR336) 2016; 374 AE Muller (137_CR382) 2017; 180 K Hawk (137_CR334) 2018; 13 NK Martin (137_CR235) 2016; 65 CM Jones (137_CR15) 2013; 132 TN Greenwell (137_CR118) 2009; 14 E Oviedo-Joekes (137_CR301) 2009; 361 D Nguyen Bich (137_CR252) 2016; 69 RZ Goldstein (137_CR89) 2002; 159 137_CR250 Z Zhang (137_CR361) 2003; 98 DR Wesson (137_CR265) 2003; 35 SL Walsh (137_CR284) 1995; 119 LM Squeglia (137_CR283) 2019 L Gowing (137_CR268) 2016; 3 L Degenhardt (137_CR86) 2017; 5 SS Martins (137_CR71) 2012; 42 HD Nelson (137_CR175) 1996; 165 JM Bossert (137_CR130) 2005; 16 AR Levine (137_CR362) 2015; 54 137_CR386 137_CR387 ND Volkow (137_CR83) 2016; 352 GJ MacArthur (137_CR213) 2017; 39 J Macleod (137_CR66) 2013; 108 DA Fiellin (137_CR257) 2014; 174 M Doverty (137_CR161) 2001; 90 Y Fu (137_CR166) 2008; 28 WM Compton (137_CR206) 2016; 374 RC Dart (137_CR13) 2015; 372 XQ Feng (137_CR278) 2017; 10 P Moyo (137_CR198) 2017; 112 PJ Kenny (137_CR136) 2006; 26 S Luchenski (137_CR189) 2018; 391 D Dowell (137_CR41) 2016; 65 S Fazel (137_CR226) 2006; 101 137_CR195 DR |
References_xml | – ident: CR45 – volume: 5 start-page: e578 year: 2018 end-page: e587 ident: CR232 article-title: Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study publication-title: Lancet HIV doi: 10.1016/S2352-3018(18)30168-1 – volume: 108 start-page: 79 year: 1992 end-page: 84 ident: CR127 article-title: Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction publication-title: Psychopharmacology doi: 10.1007/BF02245289 – volume: 68 start-page: 388 year: 2019 end-page: 395 ident: CR204 article-title: Drug overdose deaths involving cocaine and psychostimulants with abuse potential - united states, 2003-2017 publication-title: MMWR Morb. Mortal. Wkly. Rep. doi: 10.15585/mmwr.mm6817a3 – volume: 14 start-page: 543 year: 1997 end-page: 558 ident: CR338 article-title: Drug treatment careers. A conceptual framework and existing research findings publication-title: J.Subst. Abuse Treat. doi: 10.1016/S0740-5472(97)00016-0 – volume: 111 start-page: 695 year: 2016 end-page: 705 ident: CR288 article-title: Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial publication-title: Addiction doi: 10.1111/add.13238 – volume: 37 start-page: 95 year: 2009 end-page: 100 ident: CR270 article-title: Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2008.09.007 – volume: 219 start-page: 427 year: 2014 end-page: 443 ident: CR105 article-title: β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia publication-title: Handb. Exp. Pharmacol. doi: 10.1007/978-3-642-41199-1_22 – ident: CR80 – volume: 109 start-page: 90 year: 2014 end-page: 99 ident: CR346 article-title: Causes of death in a cohort treated for opioid dependence between 1985 and 2005 publication-title: Addiction doi: 10.1111/add.12337 – volume: 87 start-page: 1345 year: 1992 end-page: 1351 ident: CR27 article-title: The incidence of illicit drug use in the United States, 1962-1989 publication-title: Br. J. Addict. doi: 10.1111/j.1360-0443.1992.tb02743.x – volume: 27 start-page: 633 year: 2001 end-page: 650 ident: CR330 article-title: Treatment process in prison therapeutic communities: motivation, participation, and outcome publication-title: Am. J. Drug Alcohol Abuse doi: 10.1081/ADA-100107660 – volume: 31 start-page: 548 year: 2007 end-page: 563 ident: CR32 article-title: Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study publication-title: Eval. Rev. doi: 10.1177/0193841X07307315 – volume: 344 year: 2012 ident: CR9 article-title: Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50 000 adults in Iran publication-title: BMJ doi: 10.1136/bmj.e2502 – volume: 46 start-page: 136 year: 2017 end-page: 145 ident: CR78 article-title: Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: a mixed methods study publication-title: Int. J. Drug Policy doi: 10.1016/j.drugpo.2017.05.023 – volume: 6 start-page: 44 year: 2011 end-page: 55 ident: CR373 article-title: The case for considering quality of life in addiction research and clinical practice publication-title: Addict. Sci. Clin. Pract. – volume: 5 start-page: CD004147 year: 2011 ident: CR317 article-title: Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence publication-title: Cochrane Database Syst. Rev. – volume: 293 start-page: 103 year: 1986 end-page: 104 ident: CR267 article-title: Opiate withdrawal: inpatient versus outpatient programmes and preferred versus random assignment to treatment publication-title: Br. Med. J. doi: 10.1136/bmj.293.6539.103 – volume: 290 start-page: 78 year: 2004 end-page: 85 ident: CR142 article-title: The addicted brain publication-title: Sci. Am. doi: 10.1038/scientificamerican0304-78 – volume: 22 start-page: 247 year: 2001 end-page: 256 ident: CR328 article-title: Methadone anonymous: a 12-step program for methadone maintained heroin addicts publication-title: Subst. Abus. – volume: 47 start-page: 293 year: 2014 end-page: 298 ident: CR371 article-title: The relationship between recovery and health-related quality of life publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2014.05.006 – volume: 8 start-page: 1445 year: 2005 end-page: 1449 ident: CR383 article-title: Is there a common molecular pathway for addiction? publication-title: Nat. Neurosci. doi: 10.1038/nn1578 – volume: 23 start-page: 281 year: 1995 end-page: 302 ident: CR60 article-title: Childhood conduct problems and attention deficit behaviors and adolescent alcohol, tobacco and illicit drug use publication-title: J. Abnorm. Child Psychol. doi: 10.1007/BF01447558 – volume: 133 start-page: 633 year: 2013 end-page: 640 ident: CR322 article-title: The twelve promises of alcoholics anonymous: psychometric measure validation and mediational testing as a 12-step specific mechanism of behavior change publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2013.08.006 – volume: 83 start-page: 147 year: 2006 end-page: 156 ident: CR29 article-title: Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2005.11.007 – volume: 106 start-page: 2186 year: 2011 end-page: 2192 ident: CR178 article-title: The increasing mortality burden of liver disease among opioid-dependent people: cohort study publication-title: Addiction doi: 10.1111/j.1360-0443.2011.03575.x – ident: CR6 – volume: 7 start-page: 289 year: 1986 end-page: 340 ident: CR185 article-title: Risks and prices: an economic analysis of drug enforcement publication-title: Crime Justice doi: 10.1086/449116 – volume: 114 start-page: 1602 year: 2019 end-page: 1613 ident: CR202 article-title: Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic publication-title: Addiction doi: 10.1111/add.14664 – volume: 377 start-page: 1506 year: 2011 end-page: 1513 ident: CR307 article-title: Injectable extended-release naltrexone for opioid dependence publication-title: Lancet doi: 10.1016/S0140-6736(11)60358-9 – ident: CR315 – volume: 76 start-page: 909 year: 2015 end-page: 915 ident: CR347 article-title: Patterns and correlates of sustained heroin abstinence: findings from the 11-year follow-up of the australian treatment outcome study publication-title: J. Stud. Alcohol. Drugs doi: 10.15288/jsad.2015.76.909 – volume: 16 start-page: 1385 year: 2016 end-page: 1398 ident: CR87 article-title: Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the global burden of disease study 2013 publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(16)30325-5 – volume: 24 start-page: 152 year: 2001 end-page: 160 ident: CR135 article-title: Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(00)00186-X – volume: 112 start-page: 605 year: 2002 end-page: 617 ident: CR173 article-title: Role of corticotropin-releasing hormone in the amygdala and bed nucleus of the stria terminalis in the behavioral, pain modulatory , and endocrine consequences of opiate withdrawal publication-title: Neuroscience doi: 10.1016/S0306-4522(02)00105-7 – volume: 99 start-page: 697 year: 2004 end-page: 707 ident: CR217 article-title: Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the national treatment outcome research study (NTORS) publication-title: Addiction doi: 10.1111/j.1360-0443.2004.00752.x – volume: 154 start-page: 230 year: 2001 end-page: 242 ident: CR285 article-title: Effects of buprenorphine/naloxone in opioid-dependent humans publication-title: Psychopharmacology doi: 10.1007/s002130000637 – volume: 79 start-page: 231 year: 2005 end-page: 240 ident: CR28 article-title: Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam cohort study among drug users publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2005.01.013 – volume: 352 start-page: i19 year: 2016 ident: CR83 article-title: Opioids in pregnancy publication-title: BMJ doi: 10.1136/bmj.i19 – volume: 33 start-page: 229 year: 2007 end-page: 241 ident: CR325 article-title: Addiction recovery: its definition and conceptual boundaries publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2007.04.015 – volume: 112 start-page: 1408 year: 2017 end-page: 1418 ident: CR224 article-title: Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England publication-title: Addiction doi: 10.1111/add.13779 – volume: 105 start-page: 1545 year: 2010 end-page: 1554 ident: CR23 article-title: Meta-analysis of drug-related deaths soon after release from prison publication-title: Addiction doi: 10.1111/j.1360-0443.2010.02990.x – ident: CR314 – ident: CR93 – volume: 100 start-page: 1496 year: 2005 end-page: 1509 ident: CR277 article-title: Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers publication-title: Addiction doi: 10.1111/j.1360-0443.2005.01232.x – volume: 167 start-page: 293 year: 2017 end-page: 301 ident: CR14 article-title: Prescription opioid use, misuse, and use disorders in u.s. adults: 2015 national survey on drug use and health publication-title: Ann. Intern. Med. doi: 10.7326/M17-0865 – volume: 110 start-page: 646 year: 2015 end-page: 655 ident: CR365 article-title: A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia publication-title: Addiction doi: 10.1111/add.12834 – start-page: e218 year: 2018 end-page: e225 ident: CR241 article-title: Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study publication-title: Lancet Public Health – volume: 142 start-page: 33 year: 2014 end-page: 40 ident: CR337 article-title: A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2014.05.011 – volume: 6 start-page: 95 year: 2017 ident: CR358 article-title: Quality of life of adolescents and young people arrive at an addiction treatment centers upon their admission, and 1, 4 and 8 months after methadone maintenance therapy publication-title: J. Educ. Health Promot doi: 10.4103/jehp.jehp_297_13 – volume: 21 start-page: 364 year: 2010 end-page: 380 ident: CR376 article-title: Quality of life among opiate-dependent individuals: a review of the literature publication-title: Int. J. Drug. Policy doi: 10.1016/j.drugpo.2010.01.010 – volume: 158 start-page: 833 year: 2017 end-page: 839 ident: CR201 article-title: Impact of the opioid safety initiative on opioid-related prescribing in veterans publication-title: Pain doi: 10.1097/j.pain.0000000000000837 – volume: 113 start-page: 173 year: 2018 end-page: 182 ident: CR231 article-title: Scaling up HCV prevention and treatment interventions in rural USA - model projections for tackling an increasing epidemic publication-title: Addiction doi: 10.1111/add.13948 – volume: 15 start-page: 211 year: 2008 end-page: 218 ident: CR238 article-title: Family carers and the prevention of heroin overdose deaths: unmet training need and overlooked intervention opportunity of resuscitation training and supply of naloxone publication-title: Drugs Educ. Prevent. Policy doi: 10.1080/09687630701731205 – volume: 2 year: 2019 ident: CR193 article-title: Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder publication-title: JAMA Netw. Open doi: 10.1001/jamanetworkopen.2019.6373 – volume: 9 start-page: CD012880 year: 2019 ident: CR329 article-title: Alcoholics Anonymous and other 12-step programs for alcohol use disorder publication-title: Cochrane Database Syst. Rev. – volume: 65 start-page: 1 year: 2016 end-page: 49 ident: CR36 article-title: CDC guideline for prescribing opioids for chronic pain – United States, 2016 publication-title: MMWR Recomm. Rep. doi: 10.15585/mmwr.rr6501e1 – volume: 99 start-page: 183 year: 2009 end-page: 192 ident: CR116 article-title: Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2008.07.012 – volume: 5 start-page: e1192 year: 2017 end-page: e1207 ident: CR86 article-title: Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(17)30375-3 – volume: 23 start-page: 238 year: 2017 end-page: 248 ident: CR374 article-title: Development of OSTQOL: a measure of quality of life for patients in opioid substitution treatment publication-title: Eur. Addict. Res. doi: 10.1159/000484239 – volume: 100 start-page: 1101 year: 2005 end-page: 1109 ident: CR293 article-title: Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy publication-title: Addiction doi: 10.1111/j.1360-0443.2005.001128.x – volume: 59 start-page: 1411 year: 2014 end-page: 1419 ident: CR81 article-title: Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012 publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciu643 – volume: 62 start-page: 1157 year: 2005 end-page: 1164 ident: CR354 article-title: Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.62.10.1157 – volume: 29 start-page: 14764 year: 2009 end-page: 14769 ident: CR163 article-title: Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4291-09.2009 – volume: 166 start-page: 26 year: 2016 end-page: 31 ident: CR162 article-title: Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2016.06.024 – volume: 146 start-page: 17 year: 2015 end-page: 23 ident: CR177 article-title: National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005-2009 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2014.09.782 – volume: 131 start-page: 823 year: 2012 end-page: 842 ident: CR144 article-title: The genetics of the opioid system and specific drug addictions publication-title: Hum. Genet. doi: 10.1007/s00439-012-1172-4 – volume: 16 start-page: 633 year: 2015 end-page: 641 ident: CR50 article-title: Racial/ethnic differences in factors that place adolescents at risk for prescription opioid misuse publication-title: Prev. Sci. doi: 10.1007/s11121-014-0514-y – ident: CR386 – volume: 66 start-page: 825 year: 2009 end-page: 833 ident: CR281 article-title: Methadone-associated QT interval prolongation and torsades de pointes publication-title: Am. J. Health Syst. Pharm. doi: 10.2146/ajhp070392 – volume: 63 start-page: 102 year: 2006 end-page: 109 ident: CR321 article-title: A randomized controlled trial of interim methadone maintenance publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.63.1.102 – volume: 66 start-page: 382 year: 2017 end-page: 386 ident: CR79 article-title: Characteristics of fentanyl overdose — Massachusetts, 2014–2016 publication-title: MMWR Morb. Mortal. Wkly Rep. doi: 10.15585/mmwr.mm6614a2 – volume: 77 start-page: 772 year: 2016 end-page: 780 ident: CR34 article-title: Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States publication-title: J. Clin. Psychiatry doi: 10.4088/JCP.15m10386 – volume: 28 start-page: 251 year: 1996 end-page: 257 ident: CR109 article-title: Improving detoxification outcomes from methadone maintenance treatment: the interrelationship of affective states and protracted withdrawal publication-title: J. Psychoact. Drugs doi: 10.1080/02791072.1996.10472486 – volume: 21 start-page: 74 year: 2013 end-page: 83 ident: CR306 article-title: Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users publication-title: Exp. Clin. Psychopharmacol. doi: 10.1037/a0030743 – volume: 31 start-page: 199 year: 2012 end-page: 206 ident: CR326 article-title: Medication-assisted recovery from opioid addiction: historical and contemporary perspectives publication-title: J. Addict. Dis. doi: 10.1080/10550887.2012.694597 – volume: 52 start-page: 157 year: 1990 end-page: 169 ident: CR58 article-title: Divorce, remarriage, and adolescent drug involvement: a prospective longitudinal study publication-title: J. Marriage Family doi: 10.2307/352847 – volume: 355 start-page: 365 year: 2006 end-page: 374 ident: CR319 article-title: Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa055255 – volume: 87 start-page: 1644 year: 2016 end-page: 1656 ident: CR190 article-title: Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study publication-title: Lancet doi: 10.1016/S0140-6736(16)00161-6 – ident: CR387 – volume: 247 start-page: 47 year: 1988 end-page: 53 ident: CR274 article-title: Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans publication-title: J. Pharmacol. Exp. Ther. – volume: 243 start-page: 91 year: 1982 end-page: 105 ident: CR96 article-title: Drug reinforcement studied by the use of place conditioning in rat publication-title: Brain Res. doi: 10.1016/0006-8993(82)91123-4 – volume: 108 start-page: 1675 year: 2018 end-page: 1681 ident: CR5 article-title: Estimated prevalence of opioid use disorder in massachusetts, 2011-2015: a capture-recapture analysis publication-title: Am. J. Public Health doi: 10.2105/AJPH.2018.304673 – volume: 78 start-page: 474 year: 2015 end-page: 484 ident: CR146 article-title: Cis-expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2015.01.003 – volume: 16 start-page: CD001333 year: 2011 ident: CR305 article-title: Oral naltrexone maintenance treatment for opioid dependence publication-title: Cochrane Database Syst. Rev. – volume: 76 start-page: 88 year: 2017 end-page: 93 ident: CR370 article-title: Quality of life as an outcome of opioid use disorder treatment: a systematic review publication-title: J. Substance Abuse Treat. doi: 10.1016/j.jsat.2017.01.019 – volume: 28 start-page: 142 year: 2009 end-page: 153 ident: CR54 article-title: Is socioeconomic status in early life associated with drug use? A systematic review of the evidence publication-title: Drug Alcohol Rev. doi: 10.1111/j.1465-3362.2008.00042.x – volume: 74 start-page: 445 year: 2017 end-page: 455 ident: CR16 article-title: Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001-2002 to 2012-2013 national epidemiologic survey on alcohol and related conditions publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2017.0113 – volume: 341 start-page: c3172 year: 2010 ident: CR30 article-title: Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment publication-title: BMJ doi: 10.1136/bmj.c3172 – volume: 108 start-page: 1296 year: 2013 end-page: 1304 ident: CR229 article-title: Low incidence of hepatitis C virus amongst prisoners in Scotland publication-title: Addiction doi: 10.1111/add.12107 – ident: CR209 – volume: 113 start-page: 545 year: 2018 end-page: 563 ident: CR215 article-title: Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis publication-title: Addiction doi: 10.1111/add.14012 – volume: 31 start-page: 2692 year: 2006 end-page: 2707 ident: CR95 article-title: Unlimited access to heroin self-administration: independent motivational markers of opiate dependence publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301008 – volume: 753 start-page: 73 year: 2015 end-page: 87 ident: CR112 article-title: The dark side of emotion: the addiction perspective publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2014.11.044 – volume: 10 start-page: 295 year: 2007 end-page: 317 ident: CR61 article-title: A systematic review of the relationship between high school dropout and substance use publication-title: Clin. Child Family Psychol. Rev. doi: 10.1007/s10567-007-0023-7 – volume: 17 year: 2017 ident: CR68 article-title: Relationship between interpersonal trauma exposure and addictive behaviors: a systematic review publication-title: BMC Psychiatry doi: 10.1186/s12888-017-1323-1 – volume: 38 start-page: 3 year: 2017 end-page: 8 ident: CR205 article-title: Turning the tide or riptide? The changing opioid epidemic publication-title: Subst. Abus. doi: 10.1080/08897077.2016.1261070 – volume: 39 start-page: 121 year: 2017 end-page: 129 ident: CR248 article-title: Drug decriminalization and the price of illicit drugs publication-title: Int. J. Drug Policy doi: 10.1016/j.drugpo.2016.10.014 – volume: 79 start-page: 434 year: 2002 end-page: 435 ident: CR180 article-title: Population impact of mass incarceration under New York’s rockefeller drug laws: an analysis of years of life lost publication-title: J. Urban Health doi: 10.1093/jurban/79.3.434 – ident: CR291 – volume: 18 start-page: 381 year: 2009 end-page: 395 ident: CR25 article-title: Estimating the prevalence of ex-injecting drug use in the population publication-title: Stat. Methods Med. Res. doi: 10.1177/0962280208094704 – volume: 38 start-page: 265 year: 2017 end-page: 268 ident: CR44 article-title: Self-regulating profession? Administrative discipline of “pill mill” physicians in Florida publication-title: Subst. Abus. doi: 10.1080/08897077.2017.1316812 – volume: 108 start-page: 84 year: 2010 end-page: 97 ident: CR73 article-title: Evaluating the drug use “gateway” theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the who world mental health surveys publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2009.12.001 – volume: 96 start-page: 167 year: 2008 end-page: 177 ident: CR52 article-title: The developmental antecedents of illicit drug use: evidence from a 25 year longitudinal study publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2008.03.003 – volume: 28 start-page: 32 year: 2004 end-page: 36 ident: CR335 article-title: Risk of death in prisoners after release from jail publication-title: Aust. N. Z. J. Public. Health doi: 10.1111/j.1467-842X.2004.tb00629.x – year: 2017 ident: CR239 article-title: Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-conception and maturation publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2017.05.001 – volume: 58 start-page: 503 year: 2001 end-page: 508 ident: CR21 article-title: A 33-year follow-up of narcotics addicts publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.58.5.503 – volume: 178 start-page: 764 year: 2018 end-page: 773 ident: CR292 article-title: Weekly and monthly subcutaneous buprenorphine depot formulations vs daily sublingual buprenorphine with naloxone for treatment of opioid use disorder: a randomized clinical trial publication-title: JAMA Intern. Med. doi: 10.1001/jamainternmed.2018.1052 – ident: CR221 – volume: 108 start-page: 182 year: 2018 end-page: 186 ident: CR72 article-title: Opioid crisis: no easy fix to its social and economic determinants publication-title: Am. J. Public Health doi: 10.2105/AJPH.2017.304187 – volume: 13 start-page: 18 year: 2018 ident: CR334 article-title: Emergency department screening and interventions for substance use disorders publication-title: Addict. Sci. Clin. Pract. doi: 10.1186/s13722-018-0117-1 – volume: 25 start-page: 297 year: 2006 end-page: 305 ident: CR187 article-title: Documenting the heroin shortage in New South Wales publication-title: Drug. Alcohol. Rev. doi: 10.1080/09595230600741024 – volume: 36 start-page: 195 year: 2013 end-page: 206 ident: CR92 article-title: Opioid receptors: distinct roles in mood disorders publication-title: Trends Neurosci. doi: 10.1016/j.tins.2012.11.002 – volume: 16 start-page: 1013 year: 2005 end-page: 1016 ident: CR130 article-title: The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking publication-title: Neuroreport doi: 10.1097/00001756-200506210-00026 – volume: 22 start-page: 241 year: 1999 end-page: 252 ident: CR153 article-title: Gender differences in substance use disorders publication-title: Psychiatr. Clin. North Am. doi: 10.1016/S0193-953X(05)70074-5 – volume: 90 start-page: 91 year: 2001 end-page: 96 ident: CR161 article-title: Hyperalgesic responses in methadone maintenance patients publication-title: Pain doi: 10.1016/S0304-3959(00)00391-2 – volume: 94 start-page: 199 year: 1999 end-page: 204 ident: CR237 article-title: Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability publication-title: Addiction doi: 10.1046/j.1360-0443.1999.9421993.x – volume: 31 start-page: 64 year: 2007 end-page: 68 ident: CR323 article-title: Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes publication-title: Alcohol Clin. Exp. Res. doi: 10.1111/j.1530-0277.2006.00273.x – volume: 23 start-page: 76 year: 2015 end-page: 89 ident: CR342 article-title: Long-term course of opioid addiction publication-title: Harv. Rev. Psychiatry doi: 10.1097/HRP.0000000000000052 – volume: 25 start-page: CD004330 year: 2005 ident: CR360 article-title: Psychosocial treatment for opiate abuse and dependence publication-title: Cochrane Database Syst. Rev. – ident: CR47 – volume: 6 start-page: 639 year: 2019 end-page: 640 ident: CR352 article-title: Rising opioid-related deaths in England and Scotland must be recognised as a public health crisis publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(19)30209-3 – volume: 315 start-page: 1624 year: 2016 end-page: 1645 ident: CR37 article-title: CDC guideline for prescribing opioids for chronic pain – United States, 2016 publication-title: JAMA doi: 10.1001/jama.2016.1464 – volume: 341 start-page: c5475 year: 2010 ident: CR233 article-title: Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK general practice research database publication-title: BMJ doi: 10.1136/bmj.c5475 – volume: 369 start-page: 1047 year: 2007 end-page: 1053 ident: CR18 article-title: Development of a rational scale to assess the harm of drugs of potential misuse publication-title: Lancet doi: 10.1016/S0140-6736(07)60464-4 – volume: 132 start-page: 128 year: 2012 end-page: 134 ident: CR182 article-title: Universal alcohol misuse prevention programmes for children and adolescents: cochrane systematic reviews publication-title: Perspect. Public Health doi: 10.1177/1757913912443487 – volume: 2 start-page: 137 year: 2005 end-page: 145 ident: CR155 article-title: Sex differences in pain perception publication-title: Gend. Med. doi: 10.1016/S1550-8579(05)80042-7 – volume: 39 start-page: 1968 year: 2014 end-page: 1977 ident: CR103 article-title: Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine publication-title: Neuropsychopharmacology doi: 10.1038/npp.2014.45 – volume: 91 start-page: 295 year: 2009 end-page: 302 ident: CR119 article-title: The α1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration publication-title: Pharmacol. Biochem. Behav. doi: 10.1016/j.pbb.2008.07.012 – volume: 110 start-page: 1975 year: 2015 end-page: 1984 ident: CR220 article-title: A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence publication-title: Addiction doi: 10.1111/add.13073 – volume: 103 start-page: 251 year: 2008 end-page: 255 ident: CR261 article-title: Acute risk of drug-related death among newly released prisoners in England and Wales publication-title: Addiction doi: 10.1111/j.1360-0443.2007.02081.x – volume: 109 start-page: 617 year: 2014 end-page: 626 ident: CR294 article-title: Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone publication-title: Addiction doi: 10.1111/add.12440 – volume: 119 start-page: 268 year: 1995 end-page: 276 ident: CR284 article-title: Effects of buprenorphine and methadone in methadone-maintained subjects publication-title: Psychopharmacology doi: 10.1007/BF02246290 – year: 2019 ident: CR283 article-title: Pharmacological treatment of youth substance use disorders publication-title: J. Child Adolesc. Psychopharmacol. doi: 10.1089/cap.2019.0009 – volume: 108 start-page: 743 year: 2013 end-page: 750 ident: CR66 article-title: Early life influences on the risk of injecting drug use: case control study based on the edinburgh addiction cohort publication-title: Addiction doi: 10.1111/add.12056 – volume: 111 start-page: 1177 year: 2016 end-page: 1187 ident: CR240 article-title: Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria publication-title: Addiction doi: 10.1111/add.13326 – volume: 408 start-page: 720 year: 2000 end-page: 723 ident: CR106 article-title: Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence publication-title: Nature doi: 10.1038/35047086 – volume: 10 start-page: 1225 year: 2017 end-page: 1239 ident: CR278 article-title: Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management publication-title: J. Pain. Res. doi: 10.2147/JPR.S138698 – volume: 11 start-page: 315 year: 2017 end-page: 319 ident: CR345 article-title: High mortality among patients with opioid use disorder in a large healthcare system publication-title: J. Addict. Med. doi: 10.1097/ADM.0000000000000312 – volume: 23 start-page: 559 year: 2013 end-page: 563 ident: CR384 article-title: Negative reinforcement in drug addiction: the darkness within publication-title: Curr. Opin. Neurobiol. doi: 10.1016/j.conb.2013.03.011 – volume: 42 start-page: 1261 year: 2012 end-page: 1272 ident: CR71 article-title: Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the national epidemiologic study on alcohol and related conditions publication-title: Psychol. Med. doi: 10.1017/S0033291711002145 – volume: 174 start-page: 1947 year: 2014 end-page: 1954 ident: CR257 article-title: Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial publication-title: JAMA Intern. Med. doi: 10.1001/jamainternmed.2014.5302 – volume: 6 start-page: 205 year: 2016 end-page: 214 ident: CR158 article-title: PET imaging reveals sex differences in κ opioid receptor availability in humans, in vivo publication-title: Am. J. Nucl. Med. Mol. Imaging – volume: 33 start-page: 13 year: 2014 end-page: 18 ident: CR369 article-title: Recovery-oriented policy and care systems in the UK and USA publication-title: Drug Alcohol Rev. doi: 10.1111/dar.12092 – volume: 89 start-page: 1379 year: 2009 end-page: 1412 ident: CR97 article-title: Reward processing by the opioid system in the brain publication-title: Physiol. Rev. doi: 10.1152/physrev.00005.2009 – volume: 318 start-page: 1065 year: 2017 end-page: 1067 ident: CR348 article-title: Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000-2015 publication-title: JAMA. doi: 10.1001/jama.2017.9308 – volume: 171 start-page: 1165 year: 2017 end-page: 1175 ident: CR107 article-title: Bias factor and therapeutic window correlate to predict safer opioid analgesics publication-title: Cell doi: 10.1016/j.cell.2017.10.035 – volume: 33 start-page: 1122 year: 1994 end-page: 1131 ident: CR56 article-title: Parental separation, adolescent psychopathology , and problem behaviors publication-title: J. Am. Acad. Child Adolesc. Psychiatry doi: 10.1097/00004583-199410000-00008 – volume: 19 start-page: 375 year: 2000 end-page: 382 ident: CR331 article-title: Therapeutic communities. Enhancing retention in treatment using “Senior professor” staff publication-title: J. Subst. Abuse Treat. doi: 10.1016/S0740-5472(00)00124-0 – volume: 107 start-page: 2983 year: 2018 end-page: 2991 ident: CR279 article-title: Methadone metabolism and drug-drug interactions: in vitro and in vivo literature review publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2018.08.025 – volume: 151 start-page: 567 year: 2010 end-page: 568 ident: CR63 article-title: Who gets high‐dose opioid therapy for chronic non‐cancer pain? publication-title: Pain doi: 10.1016/j.pain.2010.08.036 – volume: 70 start-page: 1347 year: 2013 end-page: 1354 ident: CR272 article-title: A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2013.2216 – volume: 80 start-page: 267 year: 2005 end-page: 271 ident: CR296 article-title: The effects of racemic D, L-methadone and L-methadone in substituted patients-a randomized controlled study publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2005.04.007 – ident: CR174 – ident: CR46 – volume: 1 start-page: 232 year: 1996 end-page: 254 ident: CR132 article-title: Opiates, opioids and addiction publication-title: Mol. Psychiatry – volume: 374 start-page: 1253 year: 2016 end-page: 1263 ident: CR108 article-title: Opioid abuse in chronic pain-misconceptions and mitigation strategies publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1507771 – volume: 391 start-page: 266 year: 2018 end-page: 280 ident: CR189 article-title: What works in inclusion health: overview of effective interventions for marginalised and excluded populations publication-title: Lancet doi: 10.1016/S0140-6736(17)31959-1 – volume: 79 start-page: 1395 issue: 13 year: 2019 end-page: 1418 ident: CR332 article-title: Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine publication-title: Drugs doi: 10.1007/s40265-019-01154-5 – volume: 161 start-page: 202 year: 2002 end-page: 212 ident: CR275 article-title: High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans publication-title: Psychopharmacology doi: 10.1007/s00213-002-1027-0 – volume: 63 start-page: 1094 year: 2016 end-page: 1104 ident: CR218 article-title: Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciw416 – ident: CR246 – volume: 73 start-page: 568 year: 1995 end-page: 585 ident: CR172 article-title: Spino (trigemino) parabrachiohypothalamic pathway: electrophysiological evidence for an involvement in pain processes publication-title: J. Neurophysiol. doi: 10.1152/jn.1995.73.2.568 – year: 2019 ident: CR192 article-title: Predictors of overdose death among high-risk emergency department patients with substance-related encounters: a data linkage cohort study publication-title: Ann. Emerg. Med. doi: 10.1016/j.annemergmed.2019.07.014 – volume: 24 start-page: 97 year: 2001 end-page: 129 ident: CR168 article-title: Drug addiction, dysregulation of reward, and allostasis publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(00)00195-0 – volume: 165 start-page: 31 year: 1996 end-page: 36 ident: CR175 article-title: Substance-impaired physicians probationary and voluntary treatment programs compared publication-title: West. J. Med. – volume: 2015 start-page: 368979 year: 2015 ident: CR145 article-title: Pharmacogenomics and opioid analgesics: clinical implications publication-title: Int. J. Genomics doi: 10.1155/2015/368979 – volume: 75 start-page: 999 year: 2014 end-page: 1010 ident: CR367 article-title: Elements that define recovery: the experiential perspective publication-title: J. Stud. Alcohol. Drugs doi: 10.15288/jsad.2014.75.999 – ident: CR316 – volume: 393 start-page: 1760 year: 2019 end-page: 1772 ident: CR1 article-title: Management of opioid use disorder in the USA: present status and future directions publication-title: Lancet doi: 10.1016/S0140-6736(18)33078-2 – volume: 108 start-page: 65 year: 2010 end-page: 69 ident: CR333 article-title: Mortality among drug users after discharge from inpatient treatment: an 8-year prospective study publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2009.11.008 – volume: 394 start-page: 1560 year: 2019 end-page: 1579 ident: CR38 article-title: Global patterns of opioid use and dependence: harms to populations, interventions, and future action publication-title: Lancet doi: 10.1016/S0140-6736(19)32229-9 – ident: CR152 – volume: 47 start-page: 149 year: 2015 end-page: 157 ident: CR356 article-title: Changes in quality of life following buprenorphine treatment: relationship with treatment retention and illicit opioid use publication-title: J. Psychoact. Drugs doi: 10.1080/02791072.2015.1014948 – volume: 390 start-page: 1211 year: 2017 end-page: 1259 ident: CR8 article-title: Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet doi: 10.1016/S0140-6736(17)32154-2 – volume: 36 start-page: 559 year: 2015 end-page: 574 ident: CR40 article-title: The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction publication-title: Annu. Rev. Public Health doi: 10.1146/annurev-publhealth-031914-122957 – volume: 33 start-page: 13 year: 2000 end-page: 33 ident: CR131 article-title: Stress-induced relapse to heroin and cocaine seeking in rats: a review publication-title: Brain Res. Rev. doi: 10.1016/S0165-0173(00)00024-2 – volume: 191 start-page: 55 year: 2007 end-page: 62 ident: CR299 article-title: Heroin-assisted treatment for opioid dependence: randomised controlled trial publication-title: Br. J. Psychiatry doi: 10.1192/bjp.bp.106.026112 – volume: 2 start-page: 485 year: 1979 end-page: 488 ident: CR259 article-title: Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong publication-title: Lancet doi: 10.1016/S0140-6736(79)91550-2 – volume: 316 start-page: 426 year: 1998 end-page: 428 ident: CR260 article-title: Mortality from overdose among injecting drug users recently released from prison: database linkage study publication-title: BMJ doi: 10.1136/bmj.316.7129.426 – year: 2011 ident: CR318 article-title: Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2011.121 – volume: 233 start-page: 1991 year: 2016 end-page: 2004 ident: CR129 article-title: Role of projections from ventral subiculum to nucleus accumbens shell in context-induced reinstatement of heroin seeking in rats publication-title: Psychopharmacology doi: 10.1007/s00213-015-4060-5 – volume: 76 start-page: 66 year: 2014 end-page: 74 ident: CR149 article-title: Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2013.08.034 – volume: 113 start-page: 729 year: 2018 end-page: 739 ident: CR344 article-title: Patterns of substance use and mortality risk in a cohort of ‘hard-to-reach’ polysubstance users publication-title: Addiction doi: 10.1111/add.14053 – volume: 35 start-page: 501 year: 1978 end-page: 516 ident: CR282 article-title: Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1978.01770280111012 – volume: 15 start-page: 580 year: 2015 end-page: 594 ident: CR147 article-title: Association between human pain-related genotypes and variability in opioid analgesia: an updated review publication-title: Pain Pract. doi: 10.1111/papr.12232 – volume: 375 start-page: 2504 year: 2016 end-page: 2505 ident: CR320 article-title: Interim buprenorphine vs. waiting list for opioid dependence publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc1610047 – volume: 63 start-page: 563 year: 2014 end-page: 568 ident: CR39 article-title: Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines – United States, 2012 publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 284 start-page: 1689 year: 2000 end-page: 1695 ident: CR222 article-title: Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation publication-title: JAMA doi: 10.1001/jama.284.13.1689 – volume: 23 start-page: 31 year: 2015 end-page: 40 ident: CR378 article-title: Emerging consensus on measuring addiction recovery: findings from a multi-stakeholder consultation exercise publication-title: Drugs Educ. Prev. Policy doi: 10.3109/09687637.2015.1100587 – year: 2016 ident: CR183 article-title: Prevention, early intervention, harm reduction, and treatment of substance use in young people publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(16)00002-X – volume: 66 start-page: 1197 year: 2017 end-page: 1202 ident: CR75 article-title: Deaths involving fentanyl, fentanyl analogs, and U-47700 — 10 states, July–December 2016 publication-title: MMWR Morb. Mortal. Wkly Rep. doi: 10.15585/mmwr.mm6643e1 – volume: 8 start-page: CD002209 year: 2009 ident: CR211 article-title: Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence publication-title: Cochrane Database Syst. Rev – volume: 178 start-page: 861 year: 2018 end-page: 863 ident: CR42 article-title: Association of pharmaceutical industry marketing of opioid products to physicians with subsequent opioid prescribing publication-title: JAMA Intern. Med. doi: 10.1001/jamainternmed.2018.1999 – volume: 101 start-page: 181 year: 2006 end-page: 191 ident: CR226 article-title: Substance abuse and dependence in prisoners: a systematic review publication-title: Addiction doi: 10.1111/j.1360-0443.2006.01316.x – volume: 169 start-page: 137 year: 2018 end-page: 145 ident: CR310 article-title: Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study publication-title: Ann. Intern. Med. doi: 10.7326/M17-3107 – volume: 288 start-page: 1769 year: 2000 end-page: 1772 ident: CR171 article-title: Psychological and neural mechanisms of the affective dimension of pain publication-title: Science doi: 10.1126/science.288.5472.1769 – ident: CR51 – volume: 112 start-page: 1784 year: 2017 end-page: 1796 ident: CR198 article-title: Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among medicare beneficiaries in 10 US States publication-title: Addiction doi: 10.1111/add.13860 – volume: 57 start-page: S39 issue: Suppl. 2 year: 2013 end-page: S45 ident: CR385 article-title: Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy publication-title: Clin. Infect. Dis. doi: 10.1093/cid/cit296 – volume: 69 start-page: 57 year: 2016 end-page: 63 ident: CR252 article-title: HIV patients’ preference for integrated models of addiction and HIV treatment in Vietnam publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2016.07.003 – volume: 10 start-page: 561 year: 2009 end-page: 572 ident: CR128 article-title: The glutamate homeostasis hypothesis of addiction publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn2515 – volume: 11 start-page: 1092 year: 2010 end-page: 1098 ident: CR169 article-title: Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain publication-title: Pain Med. doi: 10.1111/j.1526-4637.2010.00881.x – volume: 4 start-page: 511 year: 2003 end-page: 519 ident: CR160 article-title: Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study publication-title: J. Pain doi: 10.1016/j.jpain.2003.08.003 – volume: 36 start-page: 18 year: 2016 end-page: 26 ident: CR290 article-title: Sustained-release buprenorphine (RBP-6000) blocks the effects of opioid challenge with hydromorphone in subjects with opioid use disorder publication-title: J. Clin. Psychopharmacology doi: 10.1097/JCP.0000000000000434 – volume: 25 start-page: 307 year: 2006 end-page: 313 ident: CR188 article-title: Changes in the initiation of heroin use after a reduction in heroin supply publication-title: Drug. Alcohol. Rev. doi: 10.1080/09595230600741040 – volume: 16 start-page: 1323 year: 2016 end-page: 1327 ident: CR74 article-title: Increases in drug and opioid overdose deaths — United States, 2000–2014 publication-title: Am. J. Transplant. doi: 10.1111/ajt.13776 – volume: 98 start-page: 427 year: 2003 end-page: 439 ident: CR269 article-title: Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans publication-title: Addiction doi: 10.1046/j.1360-0443.2003.00372.x – volume: 64 start-page: 453 year: 2015 end-page: 458 ident: CR82 article-title: Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years – Kentucky , Tennessee, Virginia, and West Virginia, 2006–2012 publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 189 start-page: 1 year: 2015 end-page: 8 ident: CR12 article-title: Prescription opioid analgesic use among adults: United States, 1999-2012 publication-title: NCHS Data Brief – volume: 28 start-page: 286 year: 1973 end-page: 295 ident: CR100 article-title: Methadone – a reevaluation publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1973.01750320112017 – volume: 361 year: 2018 ident: CR186 article-title: Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016 publication-title: Science doi: 10.1126/science.aau1184 – volume: 47 start-page: 165 year: 2017 end-page: 171 ident: CR69 article-title: Developmental trajectories to heroin dependence: theoretical and clinical issues publication-title: J. Appl. Soc. Psychol. doi: 10.1111/jasp.12434 – volume: 566 start-page: 348 year: 1991 end-page: 350 ident: CR113 article-title: Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment publication-title: Brain Res. doi: 10.1016/0006-8993(91)91724-F – volume: 15 start-page: 829 year: 1941 end-page: 839 ident: CR266 article-title: The morphine abstinence syndrome, its nature and treatment publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-15-5-829 – volume: 25 start-page: 177 year: 2003 end-page: 186 ident: CR380 article-title: Recovery from opioid addiction in DATOS publication-title: J. Subst. Abuse Treat. doi: 10.1016/S0740-5472(03)00125-9 – volume: 16 start-page: 1745 year: 2015 end-page: 1758 ident: CR59 article-title: Pharmaceutical opioid use and dependence among people living with chronic pain: associations observed within the pain and opioids in treatment (POINT) cohort publication-title: Pain. Med. doi: 10.1111/pme.12773 – volume: 14 start-page: 130 year: 2009 end-page: 143 ident: CR118 article-title: Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats publication-title: Addict. Biol. doi: 10.1111/j.1369-1600.2008.00142.x – volume: 28 start-page: 3861 year: 2008 end-page: 3876 ident: CR166 article-title: Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0227-08.2008 – volume: 179 start-page: 291 year: 2017 end-page: 298 ident: CR351 article-title: Trends in heroin and pharmaceutical opioid overdose deaths in Australia publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2017.07.018 – volume: 5 start-page: 253 year: 2014 ident: CR102 article-title: Does the κ opioid receptor system contribute to pain aversion? publication-title: Front. Pharmacol. doi: 10.3389/fphar.2014.00253 – volume: 18 start-page: 22 year: 1995 end-page: 29 ident: CR91 article-title: Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications publication-title: Trends Neurosci. doi: 10.1016/0166-2236(95)93946-U – volume: 149 start-page: 115 year: 2000 end-page: 120 ident: CR134 article-title: Opiate withdrawal-induced place aversion lasts for up to 16 weeks publication-title: Psychopharmacology doi: 10.1007/s002139900358 – volume: 156 start-page: 842 year: 1999 end-page: 848 ident: CR156 article-title: Gender and age influences on human brain mu-opioid receptor binding measured by PET publication-title: Am. J. Psychiatry doi: 10.1176/ajp.156.6.842 – volume: 200 start-page: 34 year: 2019 end-page: 39 ident: CR311 article-title: Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort publication-title: Drug. Alcohol. Depend. doi: 10.1016/j.drugalcdep.2019.02.031 – ident: CR207 – volume: 134 start-page: 251 year: 2014 end-page: 258 ident: CR372 article-title: Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review publication-title: Drug. Alcohol. Depend. doi: 10.1016/j.drugalcdep.2013.10.011 – volume: 357 start-page: j1550 year: 2017 ident: CR22 article-title: Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies publication-title: BMJ doi: 10.1136/bmj.j1550 – volume: 41 start-page: 373 year: 2016 end-page: 374 ident: CR122 article-title: Dynorphin, dysphoria, and dependence: the stress of addiction publication-title: Neuropsychopharmacology doi: 10.1038/npp.2015.258 – volume: 83 start-page: S4 year: 2006 end-page: S7 ident: CR48 article-title: Abuse of prescription drugs and the risk of addiction publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2005.10.020 – volume: 372 start-page: 241 year: 2015 end-page: 248 ident: CR13 article-title: Trends in opioid analgesic abuse and mortality in the United States publication-title: N. Engl. J. Med. doi: 10.1056/NEJMsa1406143 – volume: 374 start-page: 1232 year: 2016 end-page: 1242 ident: CR336 article-title: Extended-release naltrexone to prevent opioid relapse in criminal justice offenders publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1505409 – volume: 89 start-page: 631 year: 1999 end-page: 636 ident: CR99 article-title: Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity publication-title: Neuroscience doi: 10.1016/S0306-4522(98)00652-6 – volume: 73 start-page: 447 year: 2016 end-page: 455 ident: CR304 article-title: Hydromorphone compared with diacetylmorphine for long-term opioid dependence: a randomized clinical trial publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2016.0109 – volume: 4 year: 2014 ident: CR228 article-title: Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study publication-title: BMJ Open. doi: 10.1136/bmjopen-2013-004666 – volume: 2 year: 2019 ident: CR43 article-title: Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses publication-title: JAMA Netw. Open. doi: 10.1001/jamanetworkopen.2018.6007 – volume: 376 start-page: 285 year: 2010 end-page: 301 ident: CR33 article-title: Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed publication-title: Lancet doi: 10.1016/S0140-6736(10)60742-8 – volume: 26 start-page: 199 year: 2015 end-page: 209 ident: CR249 article-title: A social cost perspective in the wake of the Portuguese strategy for the fight against drugs publication-title: Int. J. Drug Policy doi: 10.1016/j.drugpo.2014.08.017 – volume: 12 start-page: CD003020 year: 2014 ident: CR181 article-title: Universal school-based prevention for illicit drug use publication-title: Cochrane Database Syst. Rev. – volume: 67 start-page: 247 year: 2006 end-page: 257 ident: CR256 article-title: Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the national epidemiologic survey on alcohol and related conditions publication-title: J. Clin. Psychiatry doi: 10.4088/JCP.v67n0211 – volume: 16 start-page: 174 year: 1997 end-page: 182 ident: CR115 article-title: Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(96)00184-4 – volume: 54 start-page: 71 year: 1997 end-page: 80 ident: CR253 article-title: Psychiatric and substance use comorbidity among treatment-seeking opioid abusers publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1997.01830130077015 – volume: 33 start-page: 221 year: 2007 end-page: 228 ident: CR327 article-title: What is recovery? A working definition from the Betty Ford institute publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2007.06.001 – volume: 26 start-page: 5894 year: 2006 end-page: 5900 ident: CR136 article-title: Conditioned withdrawal drives heroin consumption and decreases reward sensitivity publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0740-06.2006 – volume: 70 start-page: 785 year: 2011 end-page: 793 ident: CR138 article-title: The neural basis of drug stimulus processing and craving: an activation likelihood estimation meta-analysis publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2011.05.025 – volume: 69 start-page: 973 year: 2012 end-page: 981 ident: CR308 article-title: Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2012.1a – volume: 9 start-page: CD012021 year: 2017 ident: CR216 article-title: Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs publication-title: Cochrane Database Syst. Rev. – volume: 102 start-page: 1472 year: 2007 end-page: 1482 ident: CR11 article-title: HIV risk behavior among injection drug users in Tehran, Iran publication-title: Addiction doi: 10.1111/j.1360-0443.2007.01914.x – volume: 3 start-page: CD002024 year: 2016 ident: CR268 article-title: Alpha2-adrenergic agonists for the management of opioid withdrawal publication-title: Cochrane Database Syst. Rev. – volume: 221 start-page: 227 year: 1992 end-page: 234 ident: CR114 article-title: Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(92)90706-A – volume: 35 start-page: 253 year: 2003 end-page: 259 ident: CR265 article-title: The clinical opiate withdrawal scale (COWS) publication-title: J. Psychoact. Drugs doi: 10.1080/02791072.2003.10400007 – volume: 15 start-page: 266 year: 2018 end-page: 275 ident: CR251 article-title: Integrated models of care for individuals with opioid use disorder: how do we prevent HIV and HCV? publication-title: Curr. HIV/AIDS Rep. doi: 10.1007/s11904-018-0396-x – volume: 255 start-page: 159 year: 1975 end-page: 162 ident: CR141 article-title: Morphine abstinence is associated with increased brain cyclic AMP publication-title: Nature doi: 10.1038/255159b0 – volume: 345 year: 2012 ident: CR214 article-title: Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis publication-title: BMJ doi: 10.1136/bmj.e5945 – volume: 21 start-page: 608 year: 2016 end-page: 614 ident: CR150 article-title: Evidence of CNIH3 involvement in opioid dependence publication-title: Mol. Psychiatry doi: 10.1038/mp.2015.102 – volume: 20 start-page: 6 year: 2011 end-page: 38 ident: CR67 article-title: A rapid systematic review on the association between childhood physical and sexual abuse and illicit drug use among males publication-title: Child Abuse Rev. doi: 10.1002/car.1100 – volume: 180 start-page: 431 year: 2017 end-page: 438 ident: CR382 article-title: Building abstinent networks is an important resource in improving quality of life publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2017.09.006 – volume: 85 start-page: 78 year: 2018 end-page: 83 ident: CR366 article-title: The Los Angeles county hub-and-provider network for promoting the sustained use of extended-release naltrexone (XR-NTX) in los angeles county (2010-2015) publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2017.02.011 – volume: 1 start-page: 929 year: 1978 end-page: 930 ident: CR271 article-title: Clonidine in opiate withdrawal publication-title: Lancet doi: 10.1016/S0140-6736(78)90699-2 – volume: 65 start-page: 837 year: 2016 end-page: 843 ident: CR76 article-title: Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths — 27 states, 2013–2014 publication-title: MMWR Morb. Mortal. Wkly Rep. doi: 10.15585/mmwr.mm6533a2 – volume: 189 start-page: E659 year: 2017 end-page: E666 ident: CR196 article-title: Guideline for opioid therapy and chronic noncancer pain publication-title: CMAJ doi: 10.1503/cmaj.170363 – volume: 4 start-page: e81 year: 2019 end-page: e82 ident: CR350 article-title: The opioid death crisis in Canada: crucial lessons for public health publication-title: Lancet Public Health doi: 10.1016/S2468-2667(18)30232-9 – volume: 327 start-page: 310 year: 2003 ident: CR298 article-title: Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials publication-title: BMJ doi: 10.1136/bmj.327.7410.310 – ident: CR208 – volume: 145 start-page: 48 year: 2014 end-page: 68 ident: CR242 article-title: Supervised injection services: what has been demonstrated? A systematic literature review publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2014.10.012 – ident: CR195 – volume: 16 start-page: 107 year: 1986 end-page: 122 ident: CR340 article-title: Addiction careers: etiology , treatment, and 12-year follow-up outcomes publication-title: J. Drug. Issues doi: 10.1177/002204268601600106 – volume: 66 start-page: 88 year: 2009 end-page: 94 ident: CR137 article-title: Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2008.509 – volume: 40 start-page: 304 year: 2014 end-page: 311 ident: CR255 article-title: Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity publication-title: Am. J. Drug Alcohol Abuse doi: 10.3109/00952990.2014.910519 – ident: CR64 – volume: 295 start-page: 1 year: 1991 end-page: 42 ident: CR111 article-title: Piecing together the puzzle of basal forebrain anatomy publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4757-0145-6_1 – volume: 19 year: 2019 ident: CR199 article-title: The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review publication-title: BMC Health Serv. Res. doi: 10.1186/s12913-019-4642-8 – volume: 19 start-page: 111 year: 2014 end-page: 121 ident: CR35 article-title: Association of polymorphisms with heroin dependence in a large case-control series publication-title: Addict. Biol. doi: 10.1111/j.1369-1600.2012.00445.x – volume: 377 start-page: 2306 year: 2017 end-page: 2309 ident: CR203 article-title: Coupling policymaking with evaluation - the case of the opioid crisis publication-title: N. Engl. J. Med. doi: 10.1056/NEJMp1710014 – ident: CR194 – volume: 318 start-page: 2174 year: 2017 end-page: 2174 ident: CR17 article-title: Illicit fentanyl driving opioid overdose deaths publication-title: JAMA – volume: 361 start-page: 662 year: 2003 end-page: 668 ident: CR258 article-title: 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(03)12600-1 – volume: 108 start-page: 659 year: 2013 end-page: 667 ident: CR70 article-title: Pathways to heroin dependence: time to re-appraise self-medication publication-title: Addiction doi: 10.1111/j.1360-0443.2012.04001.x – volume: 379 start-page: 71 year: 2012 end-page: 83 ident: CR2 article-title: Drug policy and the public good: evidence for effective interventions publication-title: Lancet doi: 10.1016/S0140-6736(11)61674-7 – volume: 43 start-page: 235 year: 2014 end-page: 248 ident: CR236 article-title: Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyt243 – volume: 54 start-page: 37 year: 2015 end-page: 43 ident: CR362 article-title: Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2015.01.009 – volume: 387 start-page: 1427 year: 2016 end-page: 1480 ident: CR179 article-title: Public health and international drug policy publication-title: Lancet doi: 10.1016/S0140-6736(16)00619-X – volume: 119 start-page: 23 year: 1993 end-page: 27 ident: CR276 article-title: Dose-response effects of methadone in the treatment of opioid dependence publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-119-1-199307010-00004 – volume: 386 start-page: 350 year: 2015 end-page: 359 ident: CR227 article-title: Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial publication-title: Lancet doi: 10.1016/S0140-6736(14)62338-2 – volume: 361 start-page: 777 year: 2009 end-page: 786 ident: CR301 article-title: Diacetylmorphine versus methadone for the treatment of opioid addiction publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0810635 – volume: 39 start-page: 30 year: 2017 end-page: 46 ident: CR213 article-title: Among friends: a qualitative exploration of the role of peers in young people’s alcohol use using Bourdieu’s concepts of habitus, field and capital publication-title: Sociol. Health Illn. doi: 10.1111/1467-9566.12467 – volume: 37 start-page: 483 year: 2017 end-page: 497 ident: CR341 article-title: Estimating state transitions for opioid use disorders publication-title: Med. Decis. Mak. doi: 10.1177/0272989X16683928 – volume: 127 start-page: 1 year: 2007 end-page: 2 ident: CR170 article-title: The amygdala: different pains, different mechanisms publication-title: Pain doi: 10.1016/j.pain.2006.10.004 – volume: 105 start-page: 300 year: 2010 end-page: 308 ident: CR303 article-title: Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands publication-title: Addiction doi: 10.1111/j.1360-0443.2009.02754.x – volume: 242 start-page: 715 year: 1988 end-page: 723 ident: CR117 article-title: Cellular and molecular mechanisms of drug dependence publication-title: Science doi: 10.1126/science.2903550 – volume: 160 start-page: 994 year: 2004 end-page: 1004 ident: CR26 article-title: Estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use and the number of former users: back-calculation methods and opiate overdose deaths publication-title: Am. J. Epidemiol. doi: 10.1093/aje/kwh306 – volume: 66 start-page: 564 year: 2005 end-page: 574 ident: CR254 article-title: Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions publication-title: J. Clin. Psychiatry doi: 10.4088/JCP.v66n0504 – volume: 117 start-page: 85 year: 2011 end-page: 101 ident: CR7 article-title: What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2010.11.032 – ident: CR65 – volume: 32 start-page: 1088 year: 2007 end-page: 1093 ident: CR244 article-title: Injection drug users’ perceptions regarding use of a medically supervised safer injecting facility publication-title: Addict. Behav. doi: 10.1016/j.addbeh.2006.07.013 – volume: 65 start-page: 17 year: 2016 end-page: 25 ident: CR235 article-title: Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.02.007 – volume: 22 start-page: 5100 year: 2002 end-page: 5107 ident: CR157 article-title: µ-opioid receptor-mediated antinociceptive responses differ in men and women publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.22-12-05100.2002 – volume: 343 start-page: 1291 year: 2000 end-page: 1297 ident: CR287 article-title: A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200011023431802 – volume: 23 start-page: 333 year: 2012 end-page: 337 ident: CR10 article-title: Transition to injection amongst opioid users in Iran: Implications for harm reduction publication-title: Int. J. Drug. Policy doi: 10.1016/j.drugpo.2011.09.001 – volume: 83 start-page: 163 year: 2006 end-page: 168 ident: CR126 article-title: Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2005.11.008 – volume: 90 start-page: 261 year: 2007 end-page: 269 ident: CR286 article-title: Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100 mg of daily methadone publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2007.04.006 – volume: 113 start-page: 1461 year: 2018 end-page: 1476 ident: CR234 article-title: The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom publication-title: Addiction doi: 10.1111/add.14188 – volume: 132 start-page: 107 year: 2013 end-page: 113 ident: CR62 article-title: Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2013.01.010 – volume: 2 start-page: 901 year: 2015 end-page: 908 ident: CR24 article-title: Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(15)00366-1 – volume: 28 start-page: 321 year: 2005 end-page: 329 ident: CR210 article-title: An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2005.02.007 – volume: 111 start-page: 391 year: 2016 end-page: 407 ident: CR184 article-title: Peer-led interventions to prevent tobacco, alcohol and/or drug use among young people aged 11-21 years: a systematic review and meta-analysis publication-title: Addiction doi: 10.1111/add.13224 – volume: 27 start-page: 146 year: 2016 end-page: 153 ident: CR381 article-title: Personal support networks, social capital, and risk of relapse among individuals treated for substance use issues publication-title: Int. J. Drug. Policy doi: 10.1016/j.drugpo.2015.09.009 – volume: 278 start-page: 52 year: 1997 end-page: 58 ident: CR90 article-title: Drug abuse: hedonic homeostatic dysregulation publication-title: Science doi: 10.1126/science.278.5335.52 – volume: 16 start-page: 897 year: 1996 end-page: 900 ident: CR140 article-title: Under siege: the brain on opiates publication-title: Neuron doi: 10.1016/S0896-6273(00)80110-5 – volume: 316 start-page: 282 year: 2016 end-page: 290 ident: CR289 article-title: Effect of buprenorphine implants on illicit opioid use among abstinent adults with opioid dependence treated with sublingual buprenorphine: a randomized clinical trial publication-title: JAMA doi: 10.1001/jama.2016.9382 – volume: 5 start-page: 565 year: 2004 end-page: 575 ident: CR104 article-title: State-dependent opioid control of pain publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn1431 – ident: CR324 – volume: 102 start-page: 1933 year: 2007 end-page: 1941 ident: CR85 article-title: Suicidal behaviour and associated risk factors among opioid-dependent individuals: a case-control study publication-title: Addiction doi: 10.1111/j.1360-0443.2007.01971.x – volume: 374 start-page: 154 year: 2016 end-page: 163 ident: CR206 article-title: Relationship between nonmedical prescription-opioid use and heroin use publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1508490 – year: 2015 ident: CR295 article-title: Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2015.03.081 – volume: 93 start-page: 409 year: 2000 end-page: 417 ident: CR98 article-title: Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement publication-title: Anesthesiology doi: 10.1097/00000542-200008000-00019 – volume: 21 start-page: 1469 year: 1996 end-page: 1488 ident: CR133 article-title: Opioid receptors: some perspectives from early studies of their role in normal physiology , stress responsivity , and in specific addictive diseases publication-title: Neurochem. Res. doi: 10.1007/BF02532387 – ident: CR101 – volume: 94 start-page: 961 year: 1999 end-page: 972 ident: CR176 article-title: Mechanisms of fatal opioid overdose publication-title: Addiction doi: 10.1046/j.1360-0443.1999.9479612.x – ident: CR313 – volume: 94 start-page: 368 year: 1994 end-page: 375 ident: CR55 article-title: Parenting behaviors and the onset of smoking and alcohol use: a longitudinal study publication-title: Pediatrics – volume: 33 start-page: 343 year: 2009 end-page: 352 ident: CR57 article-title: Child maltreatment as a risk factor for opioid dependence: comparison of family characteristics and type and severity of child maltreatment with a matched control group publication-title: Child Abuse Negl. doi: 10.1016/j.chiabu.2008.09.009 – ident: CR273 – volume: 14 start-page: 47 year: 2000 end-page: 67 ident: CR123 article-title: Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research publication-title: Crit. Rev. Neurobiol. doi: 10.1615/CritRevNeurobiol.v14.i1.30 – volume: 175 start-page: 1399 year: 2006 end-page: 1404 ident: CR245 article-title: Summary of findings from the evaluation of a pilot medically supervised safer injecting facility publication-title: CMAJ doi: 10.1503/cmaj.060863 – volume: 9 start-page: CD005031 year: 2011 ident: CR263 article-title: Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification publication-title: Cochrane Database Syst. Rev. – volume: 165 start-page: 159 year: 2016 end-page: 167 ident: CR377 article-title: Development and validation of ‘sure’: a patient reported outcome measure (prom) for recovery from drug and alcohol dependence publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2016.06.006 – volume: 14 start-page: 169 year: 1993 end-page: 177 ident: CR125 article-title: Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers publication-title: Synapse doi: 10.1002/syn.890140210 – ident: CR312 – volume: 195 start-page: 1000 year: 1977 end-page: 1002 ident: CR110 article-title: Conditioned narcotic withdrawal in humans publication-title: Science doi: 10.1126/science.841320 – volume: 91 start-page: 102 year: 2013 end-page: 123 ident: CR212 article-title: Mortality among people who inject drugs: a systematic review and meta-analysis publication-title: Bull. World Health Organ. doi: 10.2471/BLT.12.108282 – volume: 159 start-page: 1642 year: 2002 end-page: 1652 ident: CR89 article-title: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.159.10.1642 – ident: CR94 – volume: 35 start-page: 217 year: 2010 end-page: 238 ident: CR167 article-title: Neurocircuitry of addiction publication-title: Neuropsychopharmacology doi: 10.1038/npp.2009.110 – volume: 22 start-page: 496 year: 1998 end-page: 519 ident: CR379 article-title: Relationships between drug treatment careers and outcomes: findings from the national drug abuse treatment outcome study publication-title: Eval. Rev. doi: 10.1177/0193841X9802200404 – volume: 18 year: 2018 ident: CR197 article-title: The effects of state rules on opioid prescribing in Indiana publication-title: BMC Health Serv. Res. doi: 10.1186/s12913-018-2830-6 – volume: 109 start-page: 1306 year: 2014 end-page: 1017 ident: CR225 article-title: The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study publication-title: Addiction doi: 10.1111/add.12536 – ident: CR3 – volume: 391 start-page: 309 year: 2018 end-page: 318 ident: CR309 article-title: Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(17)32812-X – volume: 349 start-page: 1943 year: 2003 end-page: 1953 ident: CR191 article-title: Opioid therapy for chronic pain publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra025411 – volume: 28 start-page: 551 issue: 3 year: 1998 end-page: 558 ident: CR375 article-title: Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment publication-title: Psychological Medicine doi: 10.1017/S0033291798006667 – volume: 207 start-page: 5 year: 2015 end-page: 14 ident: CR302 article-title: Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction publication-title: Br. J. Psychiatry doi: 10.1192/bjp.bp.114.149195 – volume: 111 start-page: 1836 year: 2016 end-page: 1847 ident: CR49 article-title: Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian mental health survey publication-title: Addiction doi: 10.1111/add.13453 – volume: 9 start-page: 466 year: 2015 ident: CR154 article-title: Sex differences in kappa opioid receptor function and their potential impact on addiction publication-title: Front. Neurosci. doi: 10.3389/fnins.2015.00466 – ident: CR250 – volume: 2017 start-page: 397 year: 2017 end-page: 476 ident: CR353 article-title: Mortality and morbidity in the 21(st) century publication-title: Brook. Pap. Econ. Act. doi: 10.1353/eca.2017.0005 – volume: 10 start-page: 782 year: 1998 end-page: 785 ident: CR165 article-title: Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time publication-title: Eur. J. Neurosci. doi: 10.1046/j.1460-9568.1998.00083.x – volume: 20 start-page: 275 year: 2015 end-page: 284 ident: CR120 article-title: Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia publication-title: Addict. Biol. doi: 10.1111/adb.12120 – volume: 28 start-page: S63 issue: Suppl. 1 year: 2005 end-page: S72 ident: CR343 article-title: Pathways in the relapse-treatment-recovery cycle over 3 years publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2004.09.006 – volume: 2 start-page: 37 year: 2016 end-page: 45 ident: CR148 article-title: A review of genome-wide association studies of stimulant and opioid use disorders publication-title: Mol. Neuropsychiatry doi: 10.1159/000444755 – volume: 375 start-page: 1885 year: 2010 end-page: 1895 ident: CR300 article-title: Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial publication-title: Lancet doi: 10.1016/S0140-6736(10)60349-2 – volume: 6 start-page: 391 year: 2019 end-page: 402 ident: CR4 article-title: Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(19)30097-5 – volume: 11 start-page: 1 year: 2007 end-page: 171 ident: CR219 article-title: Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation publication-title: Health Technol. Assess. – ident: CR84 – volume: 57 start-page: 285 year: 2017 end-page: 308 ident: CR124 article-title: Don’t worry , be happy: endocannabinoids and cannabis at the intersection of stress and reward publication-title: Annu. Rev. Pharmacol. Toxicol. doi: 10.1146/annurev-pharmtox-010716-104615 – volume: 15 start-page: 487 year: 1990 end-page: 490 ident: CR264 article-title: The development of a short opiate withdrawal scale (SOWS) publication-title: Addictive Behav. doi: 10.1016/0306-4603(90)90036-W – volume: 122 start-page: 3387 year: 2012 end-page: 3393 ident: CR19 article-title: Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics publication-title: J. Clin. Invest. doi: 10.1172/JCI60390 – volume: 35 start-page: 4296 year: 2015 end-page: 4305 ident: CR121 article-title: κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1978-13.2015 – volume: 204 start-page: 107563 year: 2019 ident: CR200 article-title: Evidence for state, community and systems-level prevention strategies to address the opioid crisis publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2019.107563 – volume: 112 start-page: 1302 year: 2017 end-page: 1314 ident: CR230 article-title: Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland publication-title: Addiction doi: 10.1111/add.13783 – volume: 28 start-page: S51 issue: Suppl. 1 year: 2005 end-page: S62 ident: CR339 article-title: The duration and correlates of addiction and treatment careers publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2004.10.013 – volume: 3 year: 2008 ident: CR243 article-title: Estimated drug overdose deaths averted by North America’s first medically-supervised safer injection facility publication-title: PLOS ONE doi: 10.1371/journal.pone.0003351 – volume: 33 start-page: 1318 year: 2011 end-page: 1326 ident: CR139 article-title: Common biology of craving across legal and illegal drugs - a quantitative meta-analysis of cue-reactivity brain response publication-title: Eur. J. Neurosci. doi: 10.1111/j.1460-9568.2010.07590.x – volume: 101 start-page: 1752 year: 2006 end-page: 1759 ident: CR297 article-title: Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: a randomized controlled trial publication-title: Addiction doi: 10.1111/j.1360-0443.2006.01603.x – volume: 14 start-page: 1 year: 2003 end-page: 7 ident: CR159 article-title: Opioid-induced hyperalgesia: abnormal or normal pain? publication-title: Neuroreport doi: 10.1097/00001756-200301200-00001 – volume: 132 start-page: 95 year: 2013 end-page: 100 ident: CR15 article-title: Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002–2004 and 2008–2010 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2013.01.007 – volume: 171 start-page: 39 year: 2017 end-page: 49 ident: CR88 article-title: A systematic review of injecting-related injury and disease among people who inject drugs publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2016.11.029 – volume: 109 start-page: 79 year: 2014 end-page: 87 ident: CR363 article-title: Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial publication-title: Addiction doi: 10.1111/add.12333 – volume: 9 year: 2013 ident: CR151 article-title: Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors publication-title: Mol. Pain doi: 10.1186/1744-8069-9-45 – volume: 347 start-page: 237 year: 1996 end-page: 240 ident: CR223 article-title: Myths about the treatment of addiction publication-title: Lancet doi: 10.1016/S0140-6736(96)90409-2 – volume: 6 start-page: 521 year: 2005 end-page: 532 ident: CR143 article-title: The genetics of addictions: uncovering the genes publication-title: Nat. Rev. Genet. doi: 10.1038/nrg1635 – volume: 98 start-page: 673 year: 2003 end-page: 684 ident: CR361 article-title: Does retention matter? Treatment duration and improvement in drug use publication-title: Addiction doi: 10.1046/j.1360-0443.2003.00354.x – volume: 133 start-page: 37 year: 1976 end-page: 40 ident: CR20 article-title: The natural history of “chipping” publication-title: Am. J. Psychiatry doi: 10.1176/ajp.133.1.37 – volume: 107 start-page: 349 year: 2012 end-page: 358 ident: CR31 article-title: Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India publication-title: Addiction doi: 10.1111/j.1360-0443.2011.03602.x – volume: 65 start-page: 1 year: 2016 end-page: 49 ident: CR41 article-title: CDC guideline for prescribing opioids for chronic pain publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 50 start-page: 999-1022 year: 2010 ident: CR247 article-title: What can we learn from the Portuguese decriminalization of illicit drugs? publication-title: Br. J. Criminol. doi: 10.1093/bjc/azq038 – volume: 65 start-page: 1445 year: 2016 end-page: 1452 ident: CR349 article-title: Increases in drug and opioid-involved overdose deaths - United States, 2010-2015 publication-title: MMWR Morb. Mortal. Wkly. Rep. doi: 10.15585/mmwr.mm655051e1 – volume: 23 start-page: 3 year: 2005 end-page: 15 ident: CR368 article-title: Recovery publication-title: Alcohol. Treat. Q. – volume: 5 start-page: 21 year: 2011 end-page: 27 ident: CR359 article-title: Adoption and implementation of medications in addiction treatment programs publication-title: J. Addict. Med. doi: 10.1097/ADM.0b013e3181d41ddb – volume: 353 start-page: 221 year: 1999 end-page: 226 ident: CR355 article-title: Role of maintenance treatment in opioid dependence publication-title: Lancet doi: 10.1016/S0140-6736(98)05356-2 – volume: 49 start-page: 796 year: 2015 end-page: 807 ident: CR280 article-title: Drug-drug interactions with antiviral agents in people who inject drugs requiring substitution therapy publication-title: Ann. Pharmacother. doi: 10.1177/1060028015581848 – volume: 8 start-page: 176 year: 2014 end-page: 182 ident: CR364 article-title: A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic publication-title: J. Addict. Med. doi: 10.1097/ADM.0000000000000035 – volume: 108 start-page: 377 year: 2013 end-page: 384 ident: CR262 article-title: A record-linkage study of drug-related death and suicide after hospital discharge among drug-treatment clients in Scotland, 1996-2006 publication-title: Addiction doi: 10.1111/j.1360-0443.2012.04066.x – volume: 30 start-page: 258 year: 2011 end-page: 270 ident: CR164 article-title: Negative affect heightens opiate withdrawal-induced hyperalgesia in heroin dependent individuals publication-title: J. Addict. Dis. doi: 10.1080/10550887.2011.581985 – volume: 157 start-page: 121 year: 2015 end-page: 128 ident: CR357 article-title: Short term health-related quality of life improvement during opioid agonist treatment publication-title: Drug. Alcohol. Depend. doi: 10.1016/j.drugalcdep.2015.10.009 – volume: 112 start-page: 64 year: 1992 end-page: 105 ident: CR53 article-title: Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention publication-title: Psychological Bull. doi: 10.1037/0033-2909.112.1.64 – volume: 24 start-page: 1334 year: 2015 end-page: 1336 ident: CR77 article-title: Prescription opioids, abuse and public health in Canada: is fentanyl the new centre of the opioid crisis? publication-title: Pharmacoepidemiology Drug Saf. doi: 10.1002/pds.3901 – volume: 16 start-page: 1385 year: 2016 ident: 137_CR87 publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(16)30325-5 – volume: 175 start-page: 1399 year: 2006 ident: 137_CR245 publication-title: CMAJ doi: 10.1503/cmaj.060863 – volume: 374 start-page: 1232 year: 2016 ident: 137_CR336 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1505409 – ident: 137_CR194 – volume: 42 start-page: 1261 year: 2012 ident: 137_CR71 publication-title: Psychol. Med. doi: 10.1017/S0033291711002145 – volume: 341 start-page: c3172 year: 2010 ident: 137_CR30 publication-title: BMJ doi: 10.1136/bmj.c3172 – volume: 110 start-page: 646 year: 2015 ident: 137_CR365 publication-title: Addiction doi: 10.1111/add.12834 – volume: 119 start-page: 268 year: 1995 ident: 137_CR284 publication-title: Psychopharmacology doi: 10.1007/BF02246290 – volume: 19 year: 2019 ident: 137_CR199 publication-title: BMC Health Serv. Res. doi: 10.1186/s12913-019-4642-8 – volume: 111 start-page: 1177 year: 2016 ident: 137_CR240 publication-title: Addiction doi: 10.1111/add.13326 – volume: 63 start-page: 1094 year: 2016 ident: 137_CR218 publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciw416 – volume: 47 start-page: 165 year: 2017 ident: 137_CR69 publication-title: J. Appl. Soc. Psychol. doi: 10.1111/jasp.12434 – volume: 28 start-page: 251 year: 1996 ident: 137_CR109 publication-title: J. Psychoact. Drugs doi: 10.1080/02791072.1996.10472486 – volume: 108 start-page: 1296 year: 2013 ident: 137_CR229 publication-title: Addiction doi: 10.1111/add.12107 – volume: 22 start-page: 5100 year: 2002 ident: 137_CR157 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.22-12-05100.2002 – volume: 14 start-page: 47 year: 2000 ident: 137_CR123 publication-title: Crit. Rev. Neurobiol. doi: 10.1615/CritRevNeurobiol.v14.i1.30 – volume: 73 start-page: 447 year: 2016 ident: 137_CR304 publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2016.0109 – volume: 10 start-page: 1225 year: 2017 ident: 137_CR278 publication-title: J. Pain. Res. doi: 10.2147/JPR.S138698 – volume: 13 start-page: 18 year: 2018 ident: 137_CR334 publication-title: Addict. Sci. Clin. Pract. doi: 10.1186/s13722-018-0117-1 – volume: 288 start-page: 1769 year: 2000 ident: 137_CR171 publication-title: Science doi: 10.1126/science.288.5472.1769 – volume: 347 start-page: 237 year: 1996 ident: 137_CR223 publication-title: Lancet doi: 10.1016/S0140-6736(96)90409-2 – volume: 114 start-page: 1602 year: 2019 ident: 137_CR202 publication-title: Addiction doi: 10.1111/add.14664 – volume: 374 start-page: 154 year: 2016 ident: 137_CR206 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1508490 – volume: 77 start-page: 772 year: 2016 ident: 137_CR34 publication-title: J. Clin. Psychiatry doi: 10.4088/JCP.15m10386 – volume: 189 start-page: 1 year: 2015 ident: 137_CR12 publication-title: NCHS Data Brief – volume: 127 start-page: 1 year: 2007 ident: 137_CR170 publication-title: Pain doi: 10.1016/j.pain.2006.10.004 – volume: 6 start-page: 639 year: 2019 ident: 137_CR352 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(19)30209-3 – volume: 19 start-page: 111 year: 2014 ident: 137_CR35 publication-title: Addict. Biol. doi: 10.1111/j.1369-1600.2012.00445.x – volume: 154 start-page: 230 year: 2001 ident: 137_CR285 publication-title: Psychopharmacology doi: 10.1007/s002130000637 – ident: 137_CR101 – volume: 4 start-page: e81 year: 2019 ident: 137_CR350 publication-title: Lancet Public Health doi: 10.1016/S2468-2667(18)30232-9 – volume: 112 start-page: 605 year: 2002 ident: 137_CR173 publication-title: Neuroscience doi: 10.1016/S0306-4522(02)00105-7 – volume: 391 start-page: 266 year: 2018 ident: 137_CR189 publication-title: Lancet doi: 10.1016/S0140-6736(17)31959-1 – volume: 369 start-page: 1047 year: 2007 ident: 137_CR18 publication-title: Lancet doi: 10.1016/S0140-6736(07)60464-4 – volume: 75 start-page: 999 year: 2014 ident: 137_CR367 publication-title: J. Stud. Alcohol. Drugs doi: 10.15288/jsad.2014.75.999 – ident: 137_CR273 – volume: 33 start-page: 13 year: 2014 ident: 137_CR369 publication-title: Drug Alcohol Rev. doi: 10.1111/dar.12092 – volume: 189 start-page: E659 year: 2017 ident: 137_CR196 publication-title: CMAJ doi: 10.1503/cmaj.170363 – volume: 133 start-page: 37 year: 1976 ident: 137_CR20 publication-title: Am. J. Psychiatry doi: 10.1176/ajp.133.1.37 – volume: 341 start-page: c5475 year: 2010 ident: 137_CR233 publication-title: BMJ doi: 10.1136/bmj.c5475 – volume: 22 start-page: 241 year: 1999 ident: 137_CR153 publication-title: Psychiatr. Clin. North Am. doi: 10.1016/S0193-953X(05)70074-5 – volume: 113 start-page: 545 year: 2018 ident: 137_CR215 publication-title: Addiction doi: 10.1111/add.14012 – ident: 137_CR3 doi: 10.1093/oso/9780198818014.001.0001 – volume: 2 start-page: 37 year: 2016 ident: 137_CR148 publication-title: Mol. Neuropsychiatry doi: 10.1159/000444755 – volume: 2017 start-page: 397 year: 2017 ident: 137_CR353 publication-title: Brook. Pap. Econ. Act. doi: 10.1353/eca.2017.0005 – volume: 156 start-page: 842 year: 1999 ident: 137_CR156 publication-title: Am. J. Psychiatry doi: 10.1176/ajp.156.6.842 – volume: 100 start-page: 1101 year: 2005 ident: 137_CR293 publication-title: Addiction doi: 10.1111/j.1360-0443.2005.001128.x – volume: 108 start-page: 1675 year: 2018 ident: 137_CR5 publication-title: Am. J. Public Health doi: 10.2105/AJPH.2018.304673 – volume: 109 start-page: 90 year: 2014 ident: 137_CR346 publication-title: Addiction doi: 10.1111/add.12337 – volume: 204 start-page: 107563 year: 2019 ident: 137_CR200 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2019.107563 – volume: 353 start-page: 221 year: 1999 ident: 137_CR355 publication-title: Lancet doi: 10.1016/S0140-6736(98)05356-2 – volume: 161 start-page: 202 year: 2002 ident: 137_CR275 publication-title: Psychopharmacology doi: 10.1007/s00213-002-1027-0 – volume: 393 start-page: 1760 year: 2019 ident: 137_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(18)33078-2 – volume: 149 start-page: 115 year: 2000 ident: 137_CR134 publication-title: Psychopharmacology doi: 10.1007/s002139900358 – volume: 9 start-page: CD012021 year: 2017 ident: 137_CR216 publication-title: Cochrane Database Syst. Rev. – volume: 96 start-page: 167 year: 2008 ident: 137_CR52 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2008.03.003 – volume: 122 start-page: 3387 year: 2012 ident: 137_CR19 publication-title: J. Clin. Invest. doi: 10.1172/JCI60390 – volume: 18 start-page: 381 year: 2009 ident: 137_CR25 publication-title: Stat. Methods Med. Res. doi: 10.1177/0962280208094704 – volume: 31 start-page: 199 year: 2012 ident: 137_CR326 publication-title: J. Addict. Dis. doi: 10.1080/10550887.2012.694597 – year: 2019 ident: 137_CR192 publication-title: Ann. Emerg. Med. doi: 10.1016/j.annemergmed.2019.07.014 – ident: 137_CR65 – volume: 25 start-page: 297 year: 2006 ident: 137_CR187 publication-title: Drug. Alcohol. Rev. doi: 10.1080/09595230600741024 – volume: 83 start-page: 163 year: 2006 ident: 137_CR126 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2005.11.008 – volume: 47 start-page: 293 year: 2014 ident: 137_CR371 publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2014.05.006 – volume: 11 start-page: 315 year: 2017 ident: 137_CR345 publication-title: J. Addict. Med. doi: 10.1097/ADM.0000000000000312 – volume: 16 start-page: 633 year: 2015 ident: 137_CR50 publication-title: Prev. Sci. doi: 10.1007/s11121-014-0514-y – volume: 6 start-page: 391 year: 2019 ident: 137_CR4 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(19)30097-5 – volume: 132 start-page: 107 year: 2013 ident: 137_CR62 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2013.01.010 – volume: 52 start-page: 157 year: 1990 ident: 137_CR58 publication-title: J. Marriage Family doi: 10.2307/352847 – volume: 113 start-page: 1461 year: 2018 ident: 137_CR234 publication-title: Addiction doi: 10.1111/add.14188 – volume: 111 start-page: 695 year: 2016 ident: 137_CR288 publication-title: Addiction doi: 10.1111/add.13238 – volume: 361 start-page: 662 year: 2003 ident: 137_CR258 publication-title: Lancet doi: 10.1016/S0140-6736(03)12600-1 – volume: 119 start-page: 23 year: 1993 ident: 137_CR276 publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-119-1-199307010-00004 – volume: 91 start-page: 102 year: 2013 ident: 137_CR212 publication-title: Bull. World Health Organ. doi: 10.2471/BLT.12.108282 – volume: 31 start-page: 2692 year: 2006 ident: 137_CR95 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301008 – volume: 31 start-page: 64 year: 2007 ident: 137_CR323 publication-title: Alcohol Clin. Exp. Res. doi: 10.1111/j.1530-0277.2006.00273.x – year: 2019 ident: 137_CR283 publication-title: J. Child Adolesc. Psychopharmacol. doi: 10.1089/cap.2019.0009 – volume: 361 year: 2018 ident: 137_CR186 publication-title: Science doi: 10.1126/science.aau1184 – volume: 158 start-page: 833 year: 2017 ident: 137_CR201 publication-title: Pain doi: 10.1097/j.pain.0000000000000837 – volume: 30 start-page: 258 year: 2011 ident: 137_CR164 publication-title: J. Addict. Dis. doi: 10.1080/10550887.2011.581985 – volume: 142 start-page: 33 year: 2014 ident: 137_CR337 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2014.05.011 – volume: 5 start-page: 253 year: 2014 ident: 137_CR102 publication-title: Front. Pharmacol. doi: 10.3389/fphar.2014.00253 – volume: 191 start-page: 55 year: 2007 ident: 137_CR299 publication-title: Br. J. Psychiatry doi: 10.1192/bjp.bp.106.026112 – volume: 2 start-page: 137 year: 2005 ident: 137_CR155 publication-title: Gend. Med. doi: 10.1016/S1550-8579(05)80042-7 – volume: 31 start-page: 548 year: 2007 ident: 137_CR32 publication-title: Eval. Rev. doi: 10.1177/0193841X07307315 – volume: 105 start-page: 300 year: 2010 ident: 137_CR303 publication-title: Addiction doi: 10.1111/j.1360-0443.2009.02754.x – volume: 94 start-page: 368 year: 1994 ident: 137_CR55 publication-title: Pediatrics doi: 10.1542/peds.94.3.368 – volume: 93 start-page: 409 year: 2000 ident: 137_CR98 publication-title: Anesthesiology doi: 10.1097/00000542-200008000-00019 – volume: 207 start-page: 5 year: 2015 ident: 137_CR302 publication-title: Br. J. Psychiatry doi: 10.1192/bjp.bp.114.149195 – volume: 111 start-page: 1836 year: 2016 ident: 137_CR49 publication-title: Addiction doi: 10.1111/add.13453 – volume: 278 start-page: 52 year: 1997 ident: 137_CR90 publication-title: Science doi: 10.1126/science.278.5335.52 – volume: 27 start-page: 633 year: 2001 ident: 137_CR330 publication-title: Am. J. Drug Alcohol Abuse doi: 10.1081/ADA-100107660 – volume: 5 start-page: 21 year: 2011 ident: 137_CR359 publication-title: J. Addict. Med. doi: 10.1097/ADM.0b013e3181d41ddb – volume: 25 start-page: 307 year: 2006 ident: 137_CR188 publication-title: Drug. Alcohol. Rev. doi: 10.1080/09595230600741040 – volume: 316 start-page: 282 year: 2016 ident: 137_CR289 publication-title: JAMA doi: 10.1001/jama.2016.9382 – volume: 76 start-page: 66 year: 2014 ident: 137_CR149 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2013.08.034 – volume: 16 start-page: 174 year: 1997 ident: 137_CR115 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(96)00184-4 – ident: 137_CR93 – volume: 78 start-page: 474 year: 2015 ident: 137_CR146 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2015.01.003 – volume: 28 start-page: S51 issue: Suppl. 1 year: 2005 ident: 137_CR339 publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2004.10.013 – ident: 137_CR174 doi: 10.1176/appi.books.9780890425596 – volume: 112 start-page: 1784 year: 2017 ident: 137_CR198 publication-title: Addiction doi: 10.1111/add.13860 – ident: 137_CR207 – volume: 70 start-page: 785 year: 2011 ident: 137_CR138 publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2011.05.025 – volume: 132 start-page: 128 year: 2012 ident: 137_CR182 publication-title: Perspect. Public Health doi: 10.1177/1757913912443487 – volume: 103 start-page: 251 year: 2008 ident: 137_CR261 publication-title: Addiction doi: 10.1111/j.1360-0443.2007.02081.x – volume: 63 start-page: 102 year: 2006 ident: 137_CR321 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.63.1.102 – volume: 23 start-page: 76 year: 2015 ident: 137_CR342 publication-title: Harv. Rev. Psychiatry doi: 10.1097/HRP.0000000000000052 – volume: 57 start-page: 285 year: 2017 ident: 137_CR124 publication-title: Annu. Rev. Pharmacol. Toxicol. doi: 10.1146/annurev-pharmtox-010716-104615 – volume: 101 start-page: 181 year: 2006 ident: 137_CR226 publication-title: Addiction doi: 10.1111/j.1360-0443.2006.01316.x – ident: 137_CR386 – volume: 35 start-page: 4296 year: 2015 ident: 137_CR121 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1978-13.2015 – volume: 94 start-page: 961 year: 1999 ident: 137_CR176 publication-title: Addiction doi: 10.1046/j.1360-0443.1999.9479612.x – volume: 33 start-page: 1122 year: 1994 ident: 137_CR56 publication-title: J. Am. Acad. Child Adolesc. Psychiatry doi: 10.1097/00004583-199410000-00008 – volume: 87 start-page: 1644 year: 2016 ident: 137_CR190 publication-title: Lancet doi: 10.1016/S0140-6736(16)00161-6 – volume: 178 start-page: 861 year: 2018 ident: 137_CR42 publication-title: JAMA Intern. Med. doi: 10.1001/jamainternmed.2018.1999 – volume: 89 start-page: 1379 year: 2009 ident: 137_CR97 publication-title: Physiol. Rev. doi: 10.1152/physrev.00005.2009 – volume: 28 start-page: 32 year: 2004 ident: 137_CR335 publication-title: Aust. N. Z. J. Public. Health doi: 10.1111/j.1467-842X.2004.tb00629.x – volume: 10 start-page: 295 year: 2007 ident: 137_CR61 publication-title: Clin. Child Family Psychol. Rev. doi: 10.1007/s10567-007-0023-7 – volume: 3 start-page: CD002024 year: 2016 ident: 137_CR268 publication-title: Cochrane Database Syst. Rev. – volume: 29 start-page: 14764 year: 2009 ident: 137_CR163 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.4291-09.2009 – volume: 166 start-page: 26 year: 2016 ident: 137_CR162 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2016.06.024 – volume: 316 start-page: 426 year: 1998 ident: 137_CR260 publication-title: BMJ doi: 10.1136/bmj.316.7129.426 – volume: 66 start-page: 825 year: 2009 ident: 137_CR281 publication-title: Am. J. Health Syst. Pharm. doi: 10.2146/ajhp070392 – volume: 233 start-page: 1991 year: 2016 ident: 137_CR129 publication-title: Psychopharmacology doi: 10.1007/s00213-015-4060-5 – volume: 5 start-page: CD004147 year: 2011 ident: 137_CR317 publication-title: Cochrane Database Syst. Rev. – volume: 5 start-page: 565 year: 2004 ident: 137_CR104 publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn1431 – volume: 19 start-page: 375 year: 2000 ident: 137_CR331 publication-title: J. Subst. Abuse Treat. doi: 10.1016/S0740-5472(00)00124-0 – ident: 137_CR47 – volume: 165 start-page: 31 year: 1996 ident: 137_CR175 publication-title: West. J. Med. – volume: 90 start-page: 261 year: 2007 ident: 137_CR286 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2007.04.006 – year: 2015 ident: 137_CR295 publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2015.03.081 – volume: 179 start-page: 291 year: 2017 ident: 137_CR351 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2017.07.018 – volume: 21 start-page: 364 year: 2010 ident: 137_CR376 publication-title: Int. J. Drug. Policy doi: 10.1016/j.drugpo.2010.01.010 – volume: 89 start-page: 631 year: 1999 ident: 137_CR99 publication-title: Neuroscience doi: 10.1016/S0306-4522(98)00652-6 – volume: 15 start-page: 829 year: 1941 ident: 137_CR266 publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-15-5-829 – volume: 41 start-page: 373 year: 2016 ident: 137_CR122 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2015.258 – volume: 4 year: 2014 ident: 137_CR228 publication-title: BMJ Open. doi: 10.1136/bmjopen-2013-004666 – volume: 21 start-page: 74 year: 2013 ident: 137_CR306 publication-title: Exp. Clin. Psychopharmacol. doi: 10.1037/a0030743 – volume: 33 start-page: 13 year: 2000 ident: 137_CR131 publication-title: Brain Res. Rev. doi: 10.1016/S0165-0173(00)00024-2 – volume: 112 start-page: 1408 year: 2017 ident: 137_CR224 publication-title: Addiction doi: 10.1111/add.13779 – volume: 46 start-page: 136 year: 2017 ident: 137_CR78 publication-title: Int. J. Drug Policy doi: 10.1016/j.drugpo.2017.05.023 – volume: 36 start-page: 195 year: 2013 ident: 137_CR92 publication-title: Trends Neurosci. doi: 10.1016/j.tins.2012.11.002 – volume: 195 start-page: 1000 year: 1977 ident: 137_CR110 publication-title: Science doi: 10.1126/science.841320 – volume: 390 start-page: 1211 year: 2017 ident: 137_CR8 publication-title: Lancet doi: 10.1016/S0140-6736(17)32154-2 – ident: 137_CR45 – volume: 387 start-page: 1427 year: 2016 ident: 137_CR179 publication-title: Lancet doi: 10.1016/S0140-6736(16)00619-X – volume: 219 start-page: 427 year: 2014 ident: 137_CR105 publication-title: Handb. Exp. Pharmacol. doi: 10.1007/978-3-642-41199-1_22 – volume: 108 start-page: 79 year: 1992 ident: 137_CR127 publication-title: Psychopharmacology doi: 10.1007/BF02245289 – volume: 357 start-page: j1550 year: 2017 ident: 137_CR22 publication-title: BMJ doi: 10.1136/bmj.j1550 – volume: 64 start-page: 453 year: 2015 ident: 137_CR82 publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 11 start-page: 1092 year: 2010 ident: 137_CR169 publication-title: Pain Med. doi: 10.1111/j.1526-4637.2010.00881.x – volume: 65 start-page: 837 year: 2016 ident: 137_CR76 publication-title: MMWR Morb. Mortal. Wkly Rep. doi: 10.15585/mmwr.mm6533a2 – volume: 33 start-page: 229 year: 2007 ident: 137_CR325 publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2007.04.015 – volume: 23 start-page: 559 year: 2013 ident: 137_CR384 publication-title: Curr. Opin. Neurobiol. doi: 10.1016/j.conb.2013.03.011 – volume: 171 start-page: 1165 year: 2017 ident: 137_CR107 publication-title: Cell doi: 10.1016/j.cell.2017.10.035 – ident: 137_CR250 – volume: 39 start-page: 121 year: 2017 ident: 137_CR248 publication-title: Int. J. Drug Policy doi: 10.1016/j.drugpo.2016.10.014 – volume: 10 start-page: 782 year: 1998 ident: 137_CR165 publication-title: Eur. J. Neurosci. doi: 10.1046/j.1460-9568.1998.00083.x – volume: 7 start-page: 289 year: 1986 ident: 137_CR185 publication-title: Crime Justice doi: 10.1086/449116 – ident: 137_CR324 doi: 10.1017/CBO9780511543883 – volume: 394 start-page: 1560 year: 2019 ident: 137_CR38 publication-title: Lancet doi: 10.1016/S0140-6736(19)32229-9 – volume: 94 start-page: 199 year: 1999 ident: 137_CR237 publication-title: Addiction doi: 10.1046/j.1360-0443.1999.9421993.x – volume: 35 start-page: 253 year: 2003 ident: 137_CR265 publication-title: J. Psychoact. Drugs doi: 10.1080/02791072.2003.10400007 – ident: 137_CR6 – volume: 1 start-page: 232 year: 1996 ident: 137_CR132 publication-title: Mol. Psychiatry – volume: 16 start-page: 1013 year: 2005 ident: 137_CR130 publication-title: Neuroreport doi: 10.1097/00001756-200506210-00026 – volume: 349 start-page: 1943 year: 2003 ident: 137_CR191 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra025411 – volume: 15 start-page: 580 year: 2015 ident: 137_CR147 publication-title: Pain Pract. doi: 10.1111/papr.12232 – volume: 106 start-page: 2186 year: 2011 ident: 137_CR178 publication-title: Addiction doi: 10.1111/j.1360-0443.2011.03575.x – volume: 11 start-page: 1 year: 2007 ident: 137_CR219 publication-title: Health Technol. Assess. – volume: 318 start-page: 2174 year: 2017 ident: 137_CR17 publication-title: JAMA – volume: 35 start-page: 217 year: 2010 ident: 137_CR167 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2009.110 – volume: 9 start-page: 466 year: 2015 ident: 137_CR154 publication-title: Front. Neurosci. doi: 10.3389/fnins.2015.00466 – volume: 22 start-page: 496 year: 1998 ident: 137_CR379 publication-title: Eval. Rev. doi: 10.1177/0193841X9802200404 – volume: 25 start-page: 177 year: 2003 ident: 137_CR380 publication-title: J. Subst. Abuse Treat. doi: 10.1016/S0740-5472(03)00125-9 – volume: 133 start-page: 633 year: 2013 ident: 137_CR322 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2013.08.006 – volume: 79 start-page: 434 year: 2002 ident: 137_CR180 publication-title: J. Urban Health doi: 10.1093/jurban/79.3.434 – volume: 180 start-page: 431 year: 2017 ident: 137_CR382 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2017.09.006 – ident: 137_CR46 – ident: 137_CR80 – volume: 372 start-page: 241 year: 2015 ident: 137_CR13 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMsa1406143 – volume: 28 start-page: 3861 year: 2008 ident: 137_CR166 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0227-08.2008 – volume: 295 start-page: 1 year: 1991 ident: 137_CR111 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4757-0145-6_1 – volume: 6 start-page: 44 year: 2011 ident: 137_CR373 publication-title: Addict. Sci. Clin. Pract. – volume: 16 start-page: 1745 year: 2015 ident: 137_CR59 publication-title: Pain. Med. doi: 10.1111/pme.12773 – volume: 753 start-page: 73 year: 2015 ident: 137_CR112 publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2014.11.044 – volume: 108 start-page: 743 year: 2013 ident: 137_CR66 publication-title: Addiction doi: 10.1111/add.12056 – volume: 2015 start-page: 368979 year: 2015 ident: 137_CR145 publication-title: Int. J. Genomics doi: 10.1155/2015/368979 – volume: 108 start-page: 659 year: 2013 ident: 137_CR70 publication-title: Addiction doi: 10.1111/j.1360-0443.2012.04001.x – volume: 377 start-page: 1506 year: 2011 ident: 137_CR307 publication-title: Lancet doi: 10.1016/S0140-6736(11)60358-9 – volume: 65 start-page: 1 year: 2016 ident: 137_CR41 publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 47 start-page: 149 year: 2015 ident: 137_CR356 publication-title: J. Psychoact. Drugs doi: 10.1080/02791072.2015.1014948 – volume: 8 start-page: 176 year: 2014 ident: 137_CR364 publication-title: J. Addict. Med. doi: 10.1097/ADM.0000000000000035 – volume: 145 start-page: 48 year: 2014 ident: 137_CR242 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2014.10.012 – volume: 23 start-page: 238 year: 2017 ident: 137_CR374 publication-title: Eur. Addict. Res. doi: 10.1159/000484239 – volume: 85 start-page: 78 year: 2018 ident: 137_CR366 publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2017.02.011 – volume: 83 start-page: S4 year: 2006 ident: 137_CR48 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2005.10.020 – volume: 113 start-page: 173 year: 2018 ident: 137_CR231 publication-title: Addiction doi: 10.1111/add.13948 – start-page: e218 volume-title: Lancet Public Health year: 2018 ident: 137_CR241 – volume: 221 start-page: 227 year: 1992 ident: 137_CR114 publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(92)90706-A – volume: 374 start-page: 1253 year: 2016 ident: 137_CR108 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1507771 – volume: 26 start-page: 5894 year: 2006 ident: 137_CR136 publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.0740-06.2006 – volume: 290 start-page: 78 year: 2004 ident: 137_CR142 publication-title: Sci. Am. doi: 10.1038/scientificamerican0304-78 – volume: 33 start-page: 343 year: 2009 ident: 137_CR57 publication-title: Child Abuse Negl. doi: 10.1016/j.chiabu.2008.09.009 – volume: 255 start-page: 159 year: 1975 ident: 137_CR141 publication-title: Nature doi: 10.1038/255159b0 – volume: 18 year: 2018 ident: 137_CR197 publication-title: BMC Health Serv. Res. doi: 10.1186/s12913-018-2830-6 – volume: 32 start-page: 1088 year: 2007 ident: 137_CR244 publication-title: Addict. Behav. doi: 10.1016/j.addbeh.2006.07.013 – ident: 137_CR314 – ident: 137_CR291 – volume: 327 start-page: 310 year: 2003 ident: 137_CR298 publication-title: BMJ doi: 10.1136/bmj.327.7410.310 – volume: 10 start-page: 561 year: 2009 ident: 137_CR128 publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn2515 – volume: 2 year: 2019 ident: 137_CR43 publication-title: JAMA Netw. Open. doi: 10.1001/jamanetworkopen.2018.6007 – volume: 108 start-page: 182 year: 2018 ident: 137_CR72 publication-title: Am. J. Public Health doi: 10.2105/AJPH.2017.304187 – volume: 73 start-page: 568 year: 1995 ident: 137_CR172 publication-title: J. Neurophysiol. doi: 10.1152/jn.1995.73.2.568 – volume: 14 start-page: 169 year: 1993 ident: 137_CR125 publication-title: Synapse doi: 10.1002/syn.890140210 – ident: 137_CR313 – volume: 20 start-page: 6 year: 2011 ident: 137_CR67 publication-title: Child Abuse Rev. doi: 10.1002/car.1100 – volume: 33 start-page: 221 year: 2007 ident: 137_CR327 publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2007.06.001 – volume: 23 start-page: 281 year: 1995 ident: 137_CR60 publication-title: J. Abnorm. Child Psychol. doi: 10.1007/BF01447558 – ident: 137_CR94 doi: 10.1007/978-1-4684-3426-2 – volume: 26 start-page: 199 year: 2015 ident: 137_CR249 publication-title: Int. J. Drug Policy doi: 10.1016/j.drugpo.2014.08.017 – volume: 284 start-page: 1689 year: 2000 ident: 137_CR222 publication-title: JAMA doi: 10.1001/jama.284.13.1689 – ident: 137_CR84 – volume: 65 start-page: 1 year: 2016 ident: 137_CR36 publication-title: MMWR Recomm. Rep. doi: 10.15585/mmwr.rr6501e1 – volume: 98 start-page: 427 year: 2003 ident: 137_CR269 publication-title: Addiction doi: 10.1046/j.1360-0443.2003.00372.x – volume: 38 start-page: 3 year: 2017 ident: 137_CR205 publication-title: Subst. Abus. doi: 10.1080/08897077.2016.1261070 – volume: 37 start-page: 95 year: 2009 ident: 137_CR270 publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2008.09.007 – volume: 391 start-page: 309 year: 2018 ident: 137_CR309 publication-title: Lancet doi: 10.1016/S0140-6736(17)32812-X – volume: 15 start-page: 266 year: 2018 ident: 137_CR251 publication-title: Curr. HIV/AIDS Rep. doi: 10.1007/s11904-018-0396-x – volume: 69 start-page: 57 year: 2016 ident: 137_CR252 publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2016.07.003 – volume: 151 start-page: 567 year: 2010 ident: 137_CR63 publication-title: Pain doi: 10.1016/j.pain.2010.08.036 – volume: 18 start-page: 22 year: 1995 ident: 137_CR91 publication-title: Trends Neurosci. doi: 10.1016/0166-2236(95)93946-U – volume: 200 start-page: 34 year: 2019 ident: 137_CR311 publication-title: Drug. Alcohol. Depend. doi: 10.1016/j.drugalcdep.2019.02.031 – volume: 318 start-page: 1065 year: 2017 ident: 137_CR348 publication-title: JAMA. doi: 10.1001/jama.2017.9308 – volume: 70 start-page: 1347 year: 2013 ident: 137_CR272 publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2013.2216 – volume: 109 start-page: 79 year: 2014 ident: 137_CR363 publication-title: Addiction doi: 10.1111/add.12333 – ident: 137_CR152 – volume: 28 start-page: S63 issue: Suppl. 1 year: 2005 ident: 137_CR343 publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2004.09.006 – volume: 5 start-page: e1192 year: 2017 ident: 137_CR86 publication-title: Lancet Glob. Health doi: 10.1016/S2214-109X(17)30375-3 – volume: 131 start-page: 823 year: 2012 ident: 137_CR144 publication-title: Hum. Genet. doi: 10.1007/s00439-012-1172-4 – volume: 27 start-page: 146 year: 2016 ident: 137_CR381 publication-title: Int. J. Drug. Policy doi: 10.1016/j.drugpo.2015.09.009 – volume: 79 start-page: 1395 issue: 13 year: 2019 ident: 137_CR332 publication-title: Drugs doi: 10.1007/s40265-019-01154-5 – volume: 74 start-page: 445 year: 2017 ident: 137_CR16 publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2017.0113 – volume: 386 start-page: 350 year: 2015 ident: 137_CR227 publication-title: Lancet doi: 10.1016/S0140-6736(14)62338-2 – volume: 16 start-page: 1323 year: 2016 ident: 137_CR74 publication-title: Am. J. Transplant. doi: 10.1111/ajt.13776 – volume: 79 start-page: 231 year: 2005 ident: 137_CR28 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2005.01.013 – year: 2011 ident: 137_CR318 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2011.121 – ident: 137_CR246 – volume: 12 start-page: CD003020 year: 2014 ident: 137_CR181 publication-title: Cochrane Database Syst. Rev. – volume: 28 start-page: 286 year: 1973 ident: 137_CR100 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1973.01750320112017 – volume: 39 start-page: 1968 year: 2014 ident: 137_CR103 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2014.45 – volume: 6 start-page: 95 year: 2017 ident: 137_CR358 publication-title: J. Educ. Health Promot doi: 10.4103/jehp.jehp_297_13 – volume: 15 start-page: 487 year: 1990 ident: 137_CR264 publication-title: Addictive Behav. doi: 10.1016/0306-4603(90)90036-W – volume: 178 start-page: 764 year: 2018 ident: 137_CR292 publication-title: JAMA Intern. Med. doi: 10.1001/jamainternmed.2018.1052 – volume: 23 start-page: 31 year: 2015 ident: 137_CR378 publication-title: Drugs Educ. Prev. Policy doi: 10.3109/09687637.2015.1100587 – volume: 247 start-page: 47 year: 1988 ident: 137_CR274 publication-title: J. Pharmacol. Exp. Ther. – volume: 1 start-page: 929 year: 1978 ident: 137_CR271 publication-title: Lancet doi: 10.1016/S0140-6736(78)90699-2 – volume: 110 start-page: 1975 year: 2015 ident: 137_CR220 publication-title: Addiction doi: 10.1111/add.13073 – volume: 16 start-page: CD001333 year: 2011 ident: 137_CR305 publication-title: Cochrane Database Syst. Rev. – volume: 36 start-page: 559 year: 2015 ident: 137_CR40 publication-title: Annu. Rev. Public Health doi: 10.1146/annurev-publhealth-031914-122957 – volume: 14 start-page: 543 year: 1997 ident: 137_CR338 publication-title: J.Subst. Abuse Treat. doi: 10.1016/S0740-5472(97)00016-0 – volume: 159 start-page: 1642 year: 2002 ident: 137_CR89 publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.159.10.1642 – volume: 108 start-page: 377 year: 2013 ident: 137_CR262 publication-title: Addiction doi: 10.1111/j.1360-0443.2012.04066.x – volume: 108 start-page: 65 year: 2010 ident: 137_CR333 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2009.11.008 – volume: 167 start-page: 293 year: 2017 ident: 137_CR14 publication-title: Ann. Intern. Med. doi: 10.7326/M17-0865 – volume: 377 start-page: 2306 year: 2017 ident: 137_CR203 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMp1710014 – volume: 107 start-page: 2983 year: 2018 ident: 137_CR279 publication-title: J. Pharm. Sci. doi: 10.1016/j.xphs.2018.08.025 – volume: 50 start-page: 999-1022 year: 2010 ident: 137_CR247 publication-title: Br. J. Criminol. doi: 10.1093/bjc/azq038 – volume: 379 start-page: 71 year: 2012 ident: 137_CR2 publication-title: Lancet doi: 10.1016/S0140-6736(11)61674-7 – volume: 16 start-page: 107 year: 1986 ident: 137_CR340 publication-title: J. Drug. Issues doi: 10.1177/002204268601600106 – volume: 67 start-page: 247 year: 2006 ident: 137_CR256 publication-title: J. Clin. Psychiatry doi: 10.4088/JCP.v67n0211 – volume: 107 start-page: 349 year: 2012 ident: 137_CR31 publication-title: Addiction doi: 10.1111/j.1360-0443.2011.03602.x – volume: 174 start-page: 1947 year: 2014 ident: 137_CR257 publication-title: JAMA Intern. Med. doi: 10.1001/jamainternmed.2014.5302 – year: 2017 ident: 137_CR239 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2017.05.001 – volume: 66 start-page: 1197 year: 2017 ident: 137_CR75 publication-title: MMWR Morb. Mortal. Wkly Rep. doi: 10.15585/mmwr.mm6643e1 – volume: 63 start-page: 563 year: 2014 ident: 137_CR39 publication-title: MMWR Morb. Mortal. Wkly Rep. – volume: 376 start-page: 285 year: 2010 ident: 137_CR33 publication-title: Lancet doi: 10.1016/S0140-6736(10)60742-8 – volume: 8 start-page: CD002209 year: 2009 ident: 137_CR211 publication-title: Cochrane Database Syst. Rev – volume: 109 start-page: 617 year: 2014 ident: 137_CR294 publication-title: Addiction doi: 10.1111/add.12440 – volume: 35 start-page: 501 year: 1978 ident: 137_CR282 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1978.01770280111012 – ident: 137_CR312 – volume: 4 start-page: 511 year: 2003 ident: 137_CR160 publication-title: J. Pain doi: 10.1016/j.jpain.2003.08.003 – ident: 137_CR64 – volume: 293 start-page: 103 year: 1986 ident: 137_CR267 publication-title: Br. Med. J. doi: 10.1136/bmj.293.6539.103 – volume: 361 start-page: 777 year: 2009 ident: 137_CR301 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0810635 – volume: 16 start-page: 897 year: 1996 ident: 137_CR140 publication-title: Neuron doi: 10.1016/S0896-6273(00)80110-5 – volume: 112 start-page: 64 year: 1992 ident: 137_CR53 publication-title: Psychological Bull. doi: 10.1037/0033-2909.112.1.64 – volume: 169 start-page: 137 year: 2018 ident: 137_CR310 publication-title: Ann. Intern. Med. doi: 10.7326/M17-3107 – volume: 102 start-page: 1933 year: 2007 ident: 137_CR85 publication-title: Addiction doi: 10.1111/j.1360-0443.2007.01971.x – volume: 91 start-page: 295 year: 2009 ident: 137_CR119 publication-title: Pharmacol. Biochem. Behav. doi: 10.1016/j.pbb.2008.07.012 – volume: 43 start-page: 235 year: 2014 ident: 137_CR236 publication-title: Int. J. Epidemiol. doi: 10.1093/ije/dyt243 – volume: 59 start-page: 1411 year: 2014 ident: 137_CR81 publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciu643 – volume: 69 start-page: 973 year: 2012 ident: 137_CR308 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2012.1a – volume: 9 start-page: CD012880 year: 2019 ident: 137_CR329 publication-title: Cochrane Database Syst. Rev. – volume: 39 start-page: 30 year: 2017 ident: 137_CR213 publication-title: Sociol. Health Illn. doi: 10.1111/1467-9566.12467 – volume: 54 start-page: 71 year: 1997 ident: 137_CR253 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.1997.01830130077015 – volume: 76 start-page: 88 year: 2017 ident: 137_CR370 publication-title: J. Substance Abuse Treat. doi: 10.1016/j.jsat.2017.01.019 – volume: 22 start-page: 247 year: 2001 ident: 137_CR328 publication-title: Subst. Abus. – volume: 66 start-page: 564 year: 2005 ident: 137_CR254 publication-title: J. Clin. Psychiatry doi: 10.4088/JCP.v66n0504 – volume: 109 start-page: 1306 year: 2014 ident: 137_CR225 publication-title: Addiction doi: 10.1111/add.12536 – volume: 65 start-page: 17 year: 2016 ident: 137_CR235 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.02.007 – volume: 344 year: 2012 ident: 137_CR9 publication-title: BMJ doi: 10.1136/bmj.e2502 – ident: 137_CR195 doi: 10.3109/15360288.2016.1173761 – volume: 54 start-page: 37 year: 2015 ident: 137_CR362 publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2015.01.009 – volume: 117 start-page: 85 year: 2011 ident: 137_CR7 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2010.11.032 – volume: 66 start-page: 88 year: 2009 ident: 137_CR137 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archgenpsychiatry.2008.509 – volume: 165 start-page: 159 year: 2016 ident: 137_CR377 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2016.06.006 – volume: 375 start-page: 1885 year: 2010 ident: 137_CR300 publication-title: Lancet doi: 10.1016/S0140-6736(10)60349-2 – volume: 343 start-page: 1291 year: 2000 ident: 137_CR287 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200011023431802 – ident: 137_CR208 – volume: 2 start-page: 901 year: 2015 ident: 137_CR24 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(15)00366-1 – volume: 242 start-page: 715 year: 1988 ident: 137_CR117 publication-title: Science doi: 10.1126/science.2903550 – volume: 62 start-page: 1157 year: 2005 ident: 137_CR354 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.62.10.1157 – volume: 25 start-page: CD004330 year: 2005 ident: 137_CR360 publication-title: Cochrane Database Syst. Rev. – volume: 345 year: 2012 ident: 137_CR214 publication-title: BMJ doi: 10.1136/bmj.e5945 – volume: 24 start-page: 97 year: 2001 ident: 137_CR168 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(00)00195-0 – volume: 108 start-page: 84 year: 2010 ident: 137_CR73 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2009.12.001 – volume: 98 start-page: 673 year: 2003 ident: 137_CR361 publication-title: Addiction doi: 10.1046/j.1360-0443.2003.00354.x – ident: 137_CR387 doi: 10.1016/B978-0-12-385870-2.00041-X – volume: 9 start-page: CD005031 year: 2011 ident: 137_CR263 publication-title: Cochrane Database Syst. Rev. – volume: 112 start-page: 1302 year: 2017 ident: 137_CR230 publication-title: Addiction doi: 10.1111/add.13783 – volume: 23 start-page: 3 year: 2005 ident: 137_CR368 publication-title: Alcohol. Treat. Q. – volume: 9 year: 2013 ident: 137_CR151 publication-title: Mol. Pain doi: 10.1186/1744-8069-9-45 – ident: 137_CR316 – volume: 76 start-page: 909 year: 2015 ident: 137_CR347 publication-title: J. Stud. Alcohol. Drugs doi: 10.15288/jsad.2015.76.909 – volume: 38 start-page: 265 year: 2017 ident: 137_CR44 publication-title: Subst. Abus. doi: 10.1080/08897077.2017.1316812 – volume: 80 start-page: 267 year: 2005 ident: 137_CR296 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2005.04.007 – volume: 90 start-page: 91 year: 2001 ident: 137_CR161 publication-title: Pain doi: 10.1016/S0304-3959(00)00391-2 – volume: 6 start-page: 205 year: 2016 ident: 137_CR158 publication-title: Am. J. Nucl. Med. Mol. Imaging – volume: 57 start-page: S39 issue: Suppl. 2 year: 2013 ident: 137_CR385 publication-title: Clin. Infect. Dis. doi: 10.1093/cid/cit296 – volume: 87 start-page: 1345 year: 1992 ident: 137_CR27 publication-title: Br. J. Addict. doi: 10.1111/j.1360-0443.1992.tb02743.x – volume: 15 start-page: 211 year: 2008 ident: 137_CR238 publication-title: Drugs Educ. Prevent. Policy doi: 10.1080/09687630701731205 – volume: 3 year: 2008 ident: 137_CR243 publication-title: PLOS ONE doi: 10.1371/journal.pone.0003351 – volume: 2 start-page: 485 year: 1979 ident: 137_CR259 publication-title: Lancet doi: 10.1016/S0140-6736(79)91550-2 – volume: 99 start-page: 183 year: 2009 ident: 137_CR116 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2008.07.012 – volume: 24 start-page: 152 year: 2001 ident: 137_CR135 publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(00)00186-X – volume: 6 start-page: 521 year: 2005 ident: 137_CR143 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg1635 – volume: 65 start-page: 1445 year: 2016 ident: 137_CR349 publication-title: MMWR Morb. Mortal. Wkly. Rep. doi: 10.15585/mmwr.mm655051e1 – volume: 83 start-page: 147 year: 2006 ident: 137_CR29 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2005.11.007 – volume: 21 start-page: 608 year: 2016 ident: 137_CR150 publication-title: Mol. Psychiatry doi: 10.1038/mp.2015.102 – volume: 134 start-page: 251 year: 2014 ident: 137_CR372 publication-title: Drug. Alcohol. Depend. doi: 10.1016/j.drugalcdep.2013.10.011 – volume: 8 start-page: 1445 year: 2005 ident: 137_CR383 publication-title: Nat. Neurosci. doi: 10.1038/nn1578 – ident: 137_CR315 – volume: 20 start-page: 275 year: 2015 ident: 137_CR120 publication-title: Addict. Biol. doi: 10.1111/adb.12120 – volume: 66 start-page: 382 year: 2017 ident: 137_CR79 publication-title: MMWR Morb. Mortal. Wkly Rep. doi: 10.15585/mmwr.mm6614a2 – ident: 137_CR221 – volume: 315 start-page: 1624 year: 2016 ident: 137_CR37 publication-title: JAMA doi: 10.1001/jama.2016.1464 – volume: 23 start-page: 333 year: 2012 ident: 137_CR10 publication-title: Int. J. Drug. Policy doi: 10.1016/j.drugpo.2011.09.001 – volume: 157 start-page: 121 year: 2015 ident: 137_CR357 publication-title: Drug. Alcohol. Depend. doi: 10.1016/j.drugalcdep.2015.10.009 – ident: 137_CR209 – volume: 100 start-page: 1496 year: 2005 ident: 137_CR277 publication-title: Addiction doi: 10.1111/j.1360-0443.2005.01232.x – volume: 111 start-page: 391 year: 2016 ident: 137_CR184 publication-title: Addiction doi: 10.1111/add.13224 – ident: 137_CR51 – volume: 40 start-page: 304 year: 2014 ident: 137_CR255 publication-title: Am. J. Drug Alcohol Abuse doi: 10.3109/00952990.2014.910519 – volume: 102 start-page: 1472 year: 2007 ident: 137_CR11 publication-title: Addiction doi: 10.1111/j.1360-0443.2007.01914.x – volume: 132 start-page: 95 year: 2013 ident: 137_CR15 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2013.01.007 – volume: 33 start-page: 1318 year: 2011 ident: 137_CR139 publication-title: Eur. J. Neurosci. doi: 10.1111/j.1460-9568.2010.07590.x – volume: 355 start-page: 365 year: 2006 ident: 137_CR319 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa055255 – volume: 58 start-page: 503 year: 2001 ident: 137_CR21 publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.58.5.503 – volume: 28 start-page: 551 issue: 3 year: 1998 ident: 137_CR375 publication-title: Psychological Medicine doi: 10.1017/S0033291798006667 – year: 2016 ident: 137_CR183 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(16)00002-X – volume: 160 start-page: 994 year: 2004 ident: 137_CR26 publication-title: Am. J. Epidemiol. doi: 10.1093/aje/kwh306 – volume: 21 start-page: 1469 year: 1996 ident: 137_CR133 publication-title: Neurochem. Res. doi: 10.1007/BF02532387 – volume: 5 start-page: e578 year: 2018 ident: 137_CR232 publication-title: Lancet HIV doi: 10.1016/S2352-3018(18)30168-1 – volume: 101 start-page: 1752 year: 2006 ident: 137_CR297 publication-title: Addiction doi: 10.1111/j.1360-0443.2006.01603.x – volume: 352 start-page: i19 year: 2016 ident: 137_CR83 publication-title: BMJ doi: 10.1136/bmj.i19 – volume: 105 start-page: 1545 year: 2010 ident: 137_CR23 publication-title: Addiction doi: 10.1111/j.1360-0443.2010.02990.x – volume: 49 start-page: 796 year: 2015 ident: 137_CR280 publication-title: Ann. Pharmacother. doi: 10.1177/1060028015581848 – volume: 36 start-page: 18 year: 2016 ident: 137_CR290 publication-title: J. Clin. Psychopharmacology doi: 10.1097/JCP.0000000000000434 – volume: 375 start-page: 2504 year: 2016 ident: 137_CR320 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc1610047 – volume: 24 start-page: 1334 year: 2015 ident: 137_CR77 publication-title: Pharmacoepidemiology Drug Saf. doi: 10.1002/pds.3901 – volume: 37 start-page: 483 year: 2017 ident: 137_CR341 publication-title: Med. Decis. Mak. doi: 10.1177/0272989X16683928 – volume: 2 year: 2019 ident: 137_CR193 publication-title: JAMA Netw. Open doi: 10.1001/jamanetworkopen.2019.6373 – volume: 99 start-page: 697 year: 2004 ident: 137_CR217 publication-title: Addiction doi: 10.1111/j.1360-0443.2004.00752.x – volume: 28 start-page: 321 year: 2005 ident: 137_CR210 publication-title: J. Subst. Abuse Treat. doi: 10.1016/j.jsat.2005.02.007 – volume: 113 start-page: 729 year: 2018 ident: 137_CR344 publication-title: Addiction doi: 10.1111/add.14053 – volume: 14 start-page: 130 year: 2009 ident: 137_CR118 publication-title: Addict. Biol. doi: 10.1111/j.1369-1600.2008.00142.x – volume: 566 start-page: 348 year: 1991 ident: 137_CR113 publication-title: Brain Res. doi: 10.1016/0006-8993(91)91724-F – volume: 14 start-page: 1 year: 2003 ident: 137_CR159 publication-title: Neuroreport doi: 10.1097/00001756-200301200-00001 – volume: 171 start-page: 39 year: 2017 ident: 137_CR88 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2016.11.029 – volume: 68 start-page: 388 year: 2019 ident: 137_CR204 publication-title: MMWR Morb. Mortal. Wkly. Rep. doi: 10.15585/mmwr.mm6817a3 – volume: 408 start-page: 720 year: 2000 ident: 137_CR106 publication-title: Nature doi: 10.1038/35047086 – volume: 17 year: 2017 ident: 137_CR68 publication-title: BMC Psychiatry doi: 10.1186/s12888-017-1323-1 – volume: 146 start-page: 17 year: 2015 ident: 137_CR177 publication-title: Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2014.09.782 – volume: 243 start-page: 91 year: 1982 ident: 137_CR96 publication-title: Brain Res. doi: 10.1016/0006-8993(82)91123-4 – volume: 28 start-page: 142 year: 2009 ident: 137_CR54 publication-title: Drug Alcohol Rev. doi: 10.1111/j.1465-3362.2008.00042.x |
SSID | ssj0001586986 |
Score | 2.59875 |
SecondaryResourceType | review_article |
Snippet | Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by activation of brain reward neurocircuits, increasingly engages... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3 |
SubjectTerms | 631/378/1662 631/378/1689/5 631/378/3920 Alcohol Biomedical research Cancer Research Councils Drug abuse Drug addiction Drug overdose Epidemiology Grants Humans Internal Medicine Medical Microbiology Medical research Medicare Medicine Medicine & Public Health Narcotic Antagonists - therapeutic use Narcotics Opiate Substitution Treatment - methods Opioid-Related Disorders - physiopathology Opioid-Related Disorders - prevention & control Opioid-Related Disorders - therapy Pharmaceutical industry Primer Public health Quality of life Quality of Life Research Research centers Scholarships & fellowships Substance abuse treatment Substance use disorder Systematic review |
Title | Opioid use disorder |
URI | https://link.springer.com/article/10.1038/s41572-019-0137-5 https://www.ncbi.nlm.nih.gov/pubmed/31919349 https://www.proquest.com/docview/2342379410 https://www.proquest.com/docview/3103047271 https://www.proquest.com/docview/2336246726 |
Volume | 6 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB7Ugggi3karRPDBg2CS3WSzT6JiEUEtYqFvIdkDBGmrbf-_M8mmRTyed7MsM7Nz5xuAEwp00JLYQIqCApRSBFLbODAhL20qGa_hmh6f0vsef-gnfZdwG7u2ykYnVopaDxXlyC9jgqpD4YnCq9FHQFOjqLrqRmgsQougy0iqRV_McyxJlsosbYqZLLsco70S1ItATUJMBMl3c_TDx_xRH63MTmcd1py_6F_XDN6ABTPYhOVHVxHfhNU67-bXvxNtQft59DZ80_50bHztkDX90y6B-H-ebUOvc_d6ex-4CQiBwrc1CSKVhSpjpYwjW6JjJYwwkQlNzItEoi_CWVkIoTU6cUwVmU2ztLQCd3AjLdOc7cDSYDgwe-BLDAU1U2ERK8Ytoeoxy0xqlY4xZIq4B2FDiFw5eHCaUvGeV2VqluU17XKkXU60yxMPzmefjGpsjP82txvq5u6ZjPM5U39drmagoSyJyIPj2TLKPxU1ioEZTukINMGo7ePUg92aabPLoHpB_5RLDy4aLs4P__Om-__f9ABWYoq5KQ0j27A0-ZyaQ3RMJuVRJX1H0Lq5e-q-fAFc_9rH |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bSxwxFD5YC60g0trb6NZOQcEqgzNJZjJ5KKXUylpd64PCvsWZXECQ3a27i_in-ht7zlx2KV7efM6FcPIl37kk5wBskqGDTOIjJQsyUEoZKetZ5GJR-kxxUadr6p1k3XPxq5_2F-Bv-xeGnlW2d2J1UduhIR_5HqNUdQieJP42-hNR1SiKrrYlNGpYHLnbGzTZxl8P93F_txg7-Hn2oxs1VQUig3idRInJY5PzUrHEl6isSCdd4mLHRJEq5HfBy0JKa1Ex4qbIfZZnpZfYQzjluRUc530Gz5F4YzL2ZF_OfTppnqk8a4OnPN8bIz9KevtAj5K4jNL_6e-OTnsnHlvR3MErWGn00_B7DajXsOAGq_Ci10TgV2G59vOF9felN9D5PbocXtpwOnahbTJ5htunVDTg-stbOH8S2byDxcFw4D5AqND0tNzEBTNceMrixz13mTeWoYmWiADiVhDaNOnIqSrGla7C4jzXtew0yk6T7HQawM5syKjOxfFY504rXd0cy7Geg-je5qrmGmJXJgF8njXjeaMgSjFwwylNgZSP7MKyAN7XmzZbDF5nqA8LFcBuu4vzyR9c6drjK_0EL7tnvWN9fHhytA5LjOx9cgGpDixOrqfuIypFk3KjQmIIF08N_X8ZhxWb |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Opioid+use+disorder&rft.jtitle=Nature+reviews.+Disease+primers&rft.au=Strang%2C+John&rft.au=Volkow%2C+Nora+D&rft.au=Degenhardt%2C+Louisa&rft.au=Hickman%2C+Matthew&rft.date=2020-01-09&rft.issn=2056-676X&rft.eissn=2056-676X&rft.volume=6&rft.issue=1&rft.spage=3&rft_id=info:doi/10.1038%2Fs41572-019-0137-5&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2056-676X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2056-676X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2056-676X&client=summon |